← 產業報告目錄

Protein Expression Market by Product (Instruments, Reagents, Kits, Consumables, Software, Services), System Type (Mammalian, Insect, Yeast), Workflow (Cloning, Translation, PTM), Scale, Protein Type, Application, Competition - Global Forecast to 2031

出版商 MarketsandMarkets產業別 Healthcare & Life Sciences出版日期 2026-05-21頁數 749報告編號 BT2757

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The global protein expression market is estimated to reach USD 7.65 billion by 2031, up from USD 5.14 billion in 2026, at a CAGR of 8.3% from 2026 to 2031. The global protein expression market is projected to witness strong growth over the forecast period, driven by the expanding biologics and biosimilars pipeline, increasing demand for recombinant proteins, and growth in advanced modalities such as cell and gene therapies and mRNA products. Market estimates indicate robust expansion through 2031, supported by technological advancements in expression systems and rising biologics manufacturing activities. However, high costs of advanced expression technologies, process scalability challenges, the need for specialized expertise, and varying regulatory requirements across regions are expected to restrain broader market growth. “The product segment accounted for the largest share, by offering, in 2025.” Based on offerings, the protein expression market is broadly segmented into products and services. In 2025, products accounted for the largest share of the protein expression market, driven by their extensive use in routine protein production workflows, including cell culture, transfection, vector preparation, protein purification, and expression optimization. Their ease of use, recurring purchase requirements, and compatibility with automated and high-throughput platforms make them essential across research and manufacturing environments. Additionally, their cost-effectiveness and ability to enable reproducible, efficient protein production continue to drive strong demand from biopharmaceutical companies, CROs, academic institutions, and research laboratories globally. “Mammalian expression systems accounted for the largest share of the protein expression market, by type, in 2025.” Based on type, the global protein expression market is segmented into mammalian, prokaryotic, insect, yeast, cell-free, and algal & plant-based expression systems. The mammalian expression systems segment accounted for the largest share of the protein expression market in 2025, due to its widespread use in producing complex recombinant proteins, monoclonal antibodies, and therapeutic biologics. These systems enable proper protein folding, post-translational modifications, and glycosylation patterns essential for biopharmaceutical applications. Additionally, the expanding biologics pipeline, increasing demand for high-quality therapeutic proteins, and growing commercial-scale manufacturing activities continue to strengthen the segment’s leading market position globally. “The Asia Pacific is growing at the highest CAGR in the protein expression market from 2026 to 2031.” The protein expression market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. During the forecast period, the Asia Pacific region is estimated to grow at the highest CAGR, driven by expanding biopharmaceutical manufacturing, rising investments in biotechnology research, and increasing demand for biologics and biosimilars. Growth is further driven by the rapid expansion of contract research and manufacturing organizations (CROs/CDMOs), improvements in healthcare and research infrastructure, and the increasing adoption of advanced protein expression technologies. Additionally, the presence of major regional and global players, including Samsung Biologics and WuXi AppTec, continues to strengthen biologics development and protein production capabilities across the region. The primary interviews conducted for this report can be categorized as follows: • By Respondent: Supply Side - 70% and Demand Side - 30% • By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30% • By Designation: CXOs and Directors - 30%, Managers - 45%, and Others - 25% • By Region: North America - 40%, Europe - 25%, Asia Pacific - 20%, Latin America - 10%, and the Middle East - 5% List of Companies Profiled in the Report • Thermo Fisher Scientific Inc. • Merck Kgaa • Danaher Corporation • Agilent Technologies, Inc • Sartorius Ag • Genscript • Takara Bio Inc. • Bio-Rad Laboratories, Inc • QIAGEN • Charles River Laboratories • Corning Incorporated • Lonza • Fujifilm Corporation • Syngene International • Lgc Limited • Eurofins Scientific • Ajinomoto Co., Inc Research Coverage This research report categorizes the protein expression market by offering, type, workflow, scale of operation, protein modality, application, by end user (product & service end users), and by region. The scope of the report covers detailed information regarding the major factors, such as drivers, challenges, opportunities, and restraints, influencing the growth of the protein expression market. A detailed analysis of the key industry players has been done to provide insights into their business overview, product portfolio, key strategies such as product and service approvals and launches, collaborations, partnerships, expansions, agreements, and recent developments associated with the protein expression market. This report covers competitive analysis of top players and upcoming startups in the protein expression market ecosystem. Key Benefits of Buying the Report The report will help market leaders/new entrants by providing the closest approximations of revenue for the overall protein expression market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their business more effectively and develop suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide information on key market drivers, restraints, opportunities, and challenges. The report provides insights into the following pointers: • Analysis of key drivers (increasing global biologics and biosimilar pipeline, rising government and venture capital R&D funding, continuous innovation in expression technologies), restraints (high capital and operational costs), opportunities (emerging algal expression systems and broader adoption of platforms such as cell-free, plant-based expression systems, AI/ML-driven expression optimization) and challenges (scalability Challenge from bench to GMP manufacturing) influencing the growth of protein expression market • Product Development/Innovation: Detailed insights on newly launched products of the protein expression market • Market Development: Comprehensive information about lucrative markets – the report analyses the protein expression market across varied regions • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the protein expression market • Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players such as Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), Agilent Technologies, Inc. (US), Sartorius AG (Germany), among others
目錄 Table of Contents
1 INTRODUCTION 66 1.1 STUDY OBJECTIVES 66 1.2 MARKET DEFINITION 66 1.3 MARKET SCOPE 67 1.3.1 MARKETS COVERED 67 1.3.2 INCLUSIONS & EXCLUSIONS 68 1.3.3 YEARS CONSIDERED 69 1.3.4 CURRENCY CONSIDERED 69 1.4 STAKEHOLDERS 70 2 EXECUTIVE SUMMARY 71 2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS 71 2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS 73 2.3 DISRUPTIVE TRENDS SHAPING THE MARKET 74 2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 75 2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 76 3 PREMIUM INSIGHTS 77 3.1 PROTEIN EXPRESSION MARKET OVERVIEW 77 3.2 PROTEIN EXPRESSION MARKET, BY OFFERING & REGION 78 3.3 PROTEIN EXPRESSION MARKET: GEOGRAPHIC SNAPSHOT 79 4 MARKET OVERVIEW 80 4.1 INTRODUCTION 80 4.2 MARKET DYNAMICS 80 4.2.1 DRIVERS 81 4.2.1.1 Increasing global biologics and biosimilars pipeline 81 4.2.1.2 Rising government and venture capital R&D funding 82 4.2.1.3 Continuous innovation in expression technologies 82 4.2.2 RESTRAINTS 82 4.2.2.1 High capital and operational costs 82 4.2.3 OPPORTUNITY 83 4.2.3.1 Emerging algal expression systems and rising adoption of advanced platforms 83 4.2.3.2 Al/ML-driven expression optimization 83 4.2.4 CHALLENGES 84 4.2.4.1 Scalability challenges from bench to GMP manufacturing 84 4.3 UNMET NEEDS AND WHITE SPACES 84 4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 85 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 86 5 INDUSTRY TRENDS 87 5.1 PORTER’S FIVE FORCES ANALYSIS 87 5.1.1 THREAT OF NEW ENTRANTS 88 5.1.2 THREAT OF SUBSTITUTES 88 5.1.3 BARGAINING POWER OF BUYERS 88 5.1.4 BARGAINING POWER OF SUPPLIERS 88 5.1.5 INTENSITY OF COMPETITIVE RIVALRY 89 5.2 MACROECONOMIC OUTLOOK 89 5.2.1 INTRODUCTION 89 5.2.2 GDP TRENDS AND FORECAST 89 5.2.3 TRENDS IN GLOBAL PROTEIN EXPRESSION MARKET 90 5.3 VALUE CHAIN ANALYSIS 90 5.3.1 PROTEIN EXPRESSION PRODUCTS 91 5.3.2 PROTEIN EXPRESSION SERVICES 92 5.4 ECOSYSTEM ANALYSIS 93 5.5 PRICING ANALYSIS 94 5.5.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER, 2023-2025 94 5.5.2 INDICATIVE SELLING PRICE, BY REGION, 2025 96 5.6 TRADE ANALYSIS 97 5.6.1 IMPORT SCENARIO FOR HS CODE 902781 97 5.6.2 EXPORT SCENARIO FOR HS CODE 902781 98 5.7 KEY CONFERENCES & EVENTS 100 5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 101 5.9 INVESTMENT/FUNDING SCENARIO 101 5.10 IMPACT OF US TARIFFS—PROTEIN EXPRESSION MARKET 102 5.10.1 INTRODUCTION 102 5.10.2 KEY TARIFF RATES 103 5.10.3 PRICE IMPACT ANALYSIS 104 5.10.4 IMPACT ON COUNTRIES/REGIONS 104 5.10.4.1 North America 104 5.10.4.2 Europe 105 5.10.4.3 Asia Pacific 105 5.10.5 IMPACT ON END-USE INDUSTRIES 106 5.10.5.1 Pharmaceutical and biotechnology companies 106 5.10.5.2 Academic & Research Institutes 106 5.10.5.3 CROs & CDMOs 106 5.11 BIOMANUFACTURING CAPACITY 107 5.12 NIH FUNDING FOR PROTEIN-RELATED RESEARCH 107 6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 108 6.1 KEY TECHNOLOGIES 108 6.1.1 RECOMBINANT DNA TECHNOLOGY 108 6.1.2 TRANSFECTION TECHNOLOGIES 108 6.2 ADJACENT TECHNOLOGIES 109 6.2.1 EXTRACTION TECHNOLOGIES 109 6.3 COMPLEMENTARY TECHNOLOGIES 109 6.3.1 HIGH-THROUGHPUT TECHNOLOGIES 109 6.3.2 COMPUTATION PROTEIN DESIGNING 109 6.4 TECHNOLOGY/PRODUCT ROADMAP 110 6.5 PATENT ANALYSIS 111 6.5.1 TOP APPLICANTS/OWNERS (COMPANIES) FOR PROTEIN EXPRESSION PATENTS, 2015–2025 111 6.6 FUTURE APPLICATIONS 113 6.7 IMPACT OF AI/GEN AI ON PROTEIN EXPRESSION MARKET 113 6.7.1 TOP USE CASES AND MARKET POTENTIAL 114 6.7.2 CASE STUDIES OF AI IMPLEMENTATION IN PROTEIN EXPRESSION MARKET 115 6.7.3 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 115 6.7.4 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN PROTEIN EXPRESSION MARKET 116 7 SUSTAINABILITY AND REGULATORY LANDSCAPE 117 7.1 REGIONAL REGULATIONS AND COMPLIANCE 117 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 117 7.1.2 REGULATORY FRAMEWORK 120 7.1.3 INDUSTRY STANDARDS 122 7.2 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES 123 7.3 CERTIFICATIONS, LABELING, AND ECO-STANDARDS 123 8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 125 8.1 DECISION-MAKING PROCESS 125 8.2 KEY STAKEHOLDERS AND BUYING EVALUATION CRITERIA 126 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 126 8.2.2 KEY BUYING CRITERIA, BY END USER 126 8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 128 8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 128 8.5 MARKET PROFITABILITY 129   9 PROTEIN EXPRESSION MARKET, BY OFFERING 130 9.1 INTRODUCTION 131 9.2 PRODUCTS 131 9.2.1 REAGENTS 135 9.2.1.1 Culture media & supplements 139 9.2.1.1.1 Optimized and GMP-ready media formulations to support scalable protein expression 139 9.2.1.2 Expression vectors & plasmids 142 9.2.1.2.1 Growing production of complex proteins to propel market 142 9.2.1.3 Transduction & transfection reagents 145 9.2.1.3.1 High-efficiency gene delivery reagents to improve transient and stable protein expression 145 9.2.1.4 Competent cells 148 9.2.1.4.1 Increasing demand for therapeutic proteins to expedite growth 148 9.2.1.5 Other reagents 151 9.2.2 INSTRUMENTS 154 9.2.2.1 Bioreactors & fermenters 157 9.2.2.1.1 Rising biologics research to drive adoption of advanced bioreactor systems 157 9.2.2.2 Chromatography systems 160 9.2.2.2.1 Expanding recombinant protein and antibody research accelerates demand for automated lab-scale systems 160 9.2.2.3 Analytical instruments 164 9.2.2.3.1 Rising need for rapid protein quality assessment and characterization drives demand for analytical instruments 164 9.2.2.4 Liquid handling & automated systems 167 9.2.2.4.1 High-throughput expression screening and workflow miniaturization to propel adoption 167 9.2.2.5 Filtration systems 170 9.2.2.5.1 Growing need for rapid and scalable post-expression processing driving global adoption 170 9.2.2.6 Other instruments 173 9.2.3 CONSUMABLES 176 9.2.3.1 Chromatography & purification consumables 180 9.2.3.1.1 Increasing need for high-purity recombinant proteins is accelerating adoption 180 9.2.3.2 Filtration & separation consumables 183 9.2.3.2.1 Rising demand for rapid, small-scale protein processing workflows is driving growth 183 9.2.3.3 Other consumables 186 9.2.4 KITS 189 9.2.4.1 Expression kits 192 9.2.4.1.1 Standardized, high-throughput expression kits accelerate recombinant protein discovery and workflow reproducibility 192 9.2.4.2 Cloning & mutagenesis kits 195 9.2.4.2.1 Rapid construct engineering kits to accelerate expression-ready clone development 195 9.2.4.3 Other kits 198 9.2.5 SOFTWARE 201 9.2.5.1 AI-enabled design, codon optimization, and workflow informatics drive software adoption 201 9.3 SERVICES 204 9.3.1 CUSTOM PROTEIN EXPRESSION SERVICES 208 9.3.1.1 Rising demand for specialized recombinant protein production supports expansion of custom services 208 9.3.2 GENE SYNTHESIS & CLONING SERVICES 211 9.3.2.1 Reduced workload, improved accuracy, optimized workflows to drive demand 211 9.3.3 CELL LINE DEVELOPMENT (CLD) SERVICES 214 9.3.3.1 Outsourcing of high-yield mammalian cell line development drives growth 214 9.3.4 PROCESS DEVELOPMENT & SCALE-UP SERVICES 217 9.3.4.1 Rising need to translate expression hits into scalable preclinical protein production supports demand growth 217 10 PROTEIN EXPRESSION MARKET, BY TYPE 220 10.1 INTRODUCTION 221 10.2 MAMMALIAN CELL EXPRESSION SYSTEMS 221 10.2.1 CHINESE HAMSTER OVARY (CHO) CELL SYSTEMS 225 10.2.1.1 High viability, rapid growth, and improved expression levels to support growth 225 10.2.2 HUMAN EMBRYONIC KIDNEY (HEK 293) CELL SYSTEMS 229 10.2.2.1 Wide usage in transient transfection studies to augment growth 229 10.2.3 OTHER MAMMALIAN CELL EXPRESSION SYSTEMS 232 10.3 PROKARYOTIC EXPRESSION SYSTEMS 235 10.3.1 ESCHERICHIA COLI SYSTEMS 239 10.3.1.1 Increasing use of E. coli systems for commercial protein production to support market 239 10.3.2 BACILLUS SYSTEMS 242 10.3.2.1 Efficient secretion capabilities drive growing adoption 242 10.3.3 OTHER PROKARYOTIC EXPRESSION SYSTEMS 246 10.4 INSECT CELL EXPRESSION SYSTEMS 249 10.4.1 BACULOVIRUS SYSTEMS 252 10.4.1.1 High protein yield and expression levels of intracellular proteins through the baculovirus expression system to support growth 252 10.4.2 OTHER INSECT CELL SYSTEMS 256 10.5 YEAST EXPRESSION SYSTEMS 259 10.5.1 PICHIA SYSTEMS 263 10.5.1.1 High scalability and efficient protein production to support growth 263 10.5.2 SACCHAROMYCES SYSTEMS 266 10.5.2.1 Efficient secretory pathways and scalable recombinant protein production to support market growth 266 10.5.3 OTHER YEAST EXPRESSION SYSTEMS 269 10.6 CELL-FREE EXPRESSION SYSTEMS 272 10.6.1 E. COLI LYSATE-BASED SYSTEMS 276 10.6.1.1 Rapid and flexible platforms for protein synthesis to drive adoption 276 10.6.2 OTHER CELL-FREE EXPRESSION SYSTEMS 279 10.7 ALGAL & PLANT-BASED EXPRESSION SYSTEMS 282 10.7.1 GROWTH IN VACCINES MARKET TO SUPPORT SEGMENT 282 11 PROTEIN EXPRESSION MARKET, BY WORKFLOW 286 11.1 INTRODUCTION 287 11.2 CLONING & TRANSFECTION 287 11.2.1 CONTINUOUS REPLENISHMENT OF CONSUMABLES AND REAGENTS TO SUPPORT THE MARKET 287 11.3 TRANSCRIPTION, TRANSLATION, AND POST-TRANSLATIONAL MODIFICATION (PTM) 291 11.3.1 GROWING NEED FOR FUNCTIONAL AND STABLE PROTEINS TO DRIVE MARKET 291 11.4 EXTRACTION, PURIFICATION, AND CHARACTERIZATION 294 11.4.1 NEED TO ADHERE TO REQUIRED STANDARDS FOR SUITABLE APPLICATIONS TO DRIVE MARKET 294 12 PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION 298 12.1 INTRODUCTION 299 12.2 DISCOVERY & RESEARCH SCALE 299 12.2.1 EXPANDING BIOLOGICS PIPELINE AND FOCUS ON COMPUTATIONALLY DESIGNED PROTEINS TO AID GROWTH 299 12.3 PRECLINICAL & CHARACTERIZATION SCALE 303 12.3.1 SIGNIFICANT NUMBER OF BIOLOGIC CANDIDATES ENTERING PRE-CLINICAL DEVELOPMENT TO BOOST THE MARKET 303 12.4 PROCESS DEVELOPMENT & PILOT SCALE 306 12.4.1 INCREASING OUTSOURCING OF EXPRESSION AT PROCESS DEVELOPMENT SCALE TO SUPPORT GROWTH 306 13 PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY 310 13.1 INTRODUCTION 311 13.2 MONOCLONAL ANTIBODIES & DERIVATIVES 311 13.2.1 EXPANDING ANTIBODY DISCOVERY, BISPECIFIC DEVELOPMENT, AND MAMMALIAN EXPRESSION OPTIMIZATION DRIVE DEMAND 311 13.3 RECOMBINANT THERAPEUTIC PROTEINS 315 13.3.1 INCREASING DEVELOPMENT OF RECOMBINANT BIOLOGICS AND ENGINEERED THERAPEUTIC PROTEINS IS DRIVING DEMAND 315   13.4 VACCINES 318 13.4.1 RISING DEMAND FOR RECOMBINANT ANTIGENS AND NEXT-GENERATION VACCINE PLATFORMS DRIVES PROTEIN EXPRESSION ADOPTION IN VACCINE RESEARCH 318 13.5 ENZYMES & CATALYTIC PROTEINS 321 13.5.1 EXPANDING ENZYME ENGINEERING AND BIOCATALYSIS APPLICATIONS ARE ACCELERATING DEMAND 321 13.6 OTHER PROTEINS 324 14 PROTEIN EXPRESSION MARKET, BY APPLICATION 328 14.1 INTRODUCTION 329 14.2 THERAPEUTIC APPLICATIONS 329 14.2.1 RISING DEMAND FOR BIOLOGICS THERAPIES TO FACILITATE GROWTH 329 14.3 RESEARCH APPLICATIONS 333 14.3.1 GROWING INTEREST IN PROTEOMICS, GENOMICS, AND DRUG DISCOVERY TO BOOST MARKET 333 14.4 INDUSTRIAL APPLICATIONS 337 14.4.1 INCREASING USE OF PROTEINS IN COSMETICS, TEXTILES, AND INDUSTRIAL ENZYMES TO PROMOTE GROWTH 337 14.5 DIAGNOSTIC APPLICATIONS 341 14.5.1 RECOMBINANT PROTEINS AND ASSAY-READY REAGENTS TO STRENGTHEN DIAGNOSTIC DEVELOPMENT 341 15 PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER 345 15.1 INTRODUCTION 346 15.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 346 15.2.1 RISING INVESTMENT IN BIOLOGICS AND INCREASING APPROVALS FOR BIOLOGICS TO SUPPORT GROWTH 346 15.3 CROS & CDMOS 350 15.3.1 INCREASE IN OUTSOURCING AND COLLABORATIONS FOR PHARMACEUTICAL MANUFACTURING TO BOOST MARKET 350 15.4 ACADEMIC & RESEARCH INSTITUTES 353 15.4.1 INCREASING GOVERNMENT AND PRIVATE FUNDING TO SUPPORT MARKET 353 15.5 OTHER END USERS 357 16 PROTEIN EXPRESSION SERVICES MARKET, BY END USER 361 16.1 INTRODUCTION 362 16.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 362 16.2.1 INCREASING SHIFT TOWARD DRUG DEVELOPMENT OUTSOURCING TO FAVOR GROWTH 362 16.3 ACADEMIC & RESEARCH INSTITUTES 366 16.3.1 RISING PARTNERSHIPS BETWEEN ACADEMIA AND CONTRACT RESEARCH ORGANIZATIONS TO AID GROWTH 366 16.4 OTHER END USERS 369 17 PROTEIN EXPRESSION MARKET, BY REGION 373 17.1 INTRODUCTION 374 17.2 NORTH AMERICA 374 17.2.1 US 385 17.2.1.1 Growing focus on developing new therapeutics and protein-based drugs to drive market 385 17.2.2 CANADA 394 17.2.2.1 Increasing incidence of cancer and prevalence of public-private partnerships to sustain growth 394 17.3 EUROPE 403 17.3.1 GERMANY 411 17.3.1.1 Increasing proteomics-based research and healthcare investments to promote growth 411 17.3.2 UK 420 17.3.2.1 Growing development of immunotherapies, vaccines, and proteomics to fuel market 420 17.3.3 FRANCE 428 17.3.3.1 Rise in funding for proteomics and genomics to spur growth 428 17.3.4 ITALY 437 17.3.4.1 Growing life science research supported by universities and research institutions to boost market 437 17.3.5 SPAIN 445 17.3.5.1 Growing expansion of biotech companies and increasing R&D expenditure to drive market 445 17.3.6 NETHERLANDS 452 17.3.6.1 Presence of advanced infrastructure to fuel market 452 17.3.7 REST OF EUROPE 460 17.4 ASIA PACIFIC 470 17.4.1 CHINA 480 17.4.1.1 Rising biologics development driving market growth 480 17.4.2 JAPAN 488 17.4.2.1 Growing government initiatives and expansion of biopharma companies to boost market 488 17.4.3 INDIA 496 17.4.3.1 Rising collaborations between private sector and academia to facilitate growth 496 17.4.4 AUSTRALIA 504 17.4.4.1 Strong regulatory framework, clinical innovation, and global partnerships drive market growth 504 17.4.5 SOUTH KOREA 512 17.4.5.1 Increasing research & development of novel therapies to facilitate growth 512 17.4.6 REST OF ASIA PACIFIC 520   17.5 LATIN AMERICA 529 17.5.1 BRAZIL 537 17.5.1.1 Growing industrial investments to propel market 537 17.5.2 MEXICO 545 17.5.2.1 Increasing government support for biopharmaceutical production to drive market 545 17.5.3 ARGENTINA 552 17.5.3.1 Rise in biotechnology and pharmaceutical research & development to augment growth 552 17.5.4 REST OF LATIN AMERICA 560 17.6 MIDDLE EAST 568 17.6.1 GCC COUNTRIES 576 17.6.1.1 Saudi Arabia 584 17.6.1.1.1 Rising demand for biologics and increasing healthcare investments to support market growth 584 17.6.1.2 United Arab Emirates 592 17.6.1.2.1 Developing biopharma sector to drive market 592 17.6.1.3 Rest of GCC countries 600 17.6.2 REST OF MIDDLE EAST 608 17.7 AFRICA 617 18 COMPETITIVE LANDSCAPE 625 18.1 OVERVIEW 625 18.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 625 18.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN PROTEIN EXPRESSION MARKET 626 18.3 REVENUE ANALYSIS 627 18.4 MARKET SHARE ANALYSIS 628 18.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 630 18.5.1 STARS 630 18.5.2 EMERGING LEADERS 630 18.5.3 PERVASIVE PLAYERS 631 18.5.4 PARTICIPANTS 631 18.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 632 18.5.5.1 Company footprint 632 18.5.5.2 Region footprint 633 18.5.5.3 Offering footprint 634 18.5.5.4 Type footprint 635 18.5.5.5 Application footprint 637 18.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 638 18.6.1 PROGRESSIVE COMPANIES 638 18.6.2 RESPONSIVE COMPANIES 638 18.6.3 DYNAMIC COMPANIES 638 18.6.4 STARTING BLOCKS 638 18.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 640 18.6.5.1 Detailed list of key startups/SMEs 640 18.6.5.2 Competitive benchmarking of key startups/SMEs 641 18.7 COMPANY VALUATION AND FINANCIAL METRICS 642 18.7.1 COMPANY VALUATION 642 18.7.2 FINANCIAL METRICS 642 18.8 BRAND/PRODUCT COMPARISON 643 18.9 COMPETITIVE SCENARIO 644 18.9.1 PRODUCT & SERVICE LAUNCHES 644 18.9.2 DEALS 645 18.9.3 EXPANSIONS 646 19 COMPANY PROFILES 647 19.1 MAJOR PLAYERS 647 19.1.1 THERMO FISHER SCIENTIFIC INC. 647 19.1.1.1 Business overview 647 19.1.1.2 Products & services offered 648 19.1.1.3 Recent developments 652 19.1.1.3.1 Product & service launches 652 19.1.1.3.2 Deals 653 19.1.1.3.3 Expansions 653 19.1.1.4 MnM view 654 19.1.1.4.1 Key strengths 654 19.1.1.4.2 Strategic choices 654 19.1.1.4.3 Weaknesses and competitive threats 654 19.1.2 MERCK KGAA 655 19.1.2.1 Business overview 655 19.1.2.2 Products & services offered 656 19.1.2.3 Recent developments 659 19.1.2.3.1 Deals 659 19.1.2.3.2 Expansions 659 19.1.2.4 MnM view 661 19.1.2.4.1 Key strengths 661 19.1.2.4.2 Strategic choices 661 19.1.2.4.3 Weaknesses and competitive threats 661 19.1.3 DANAHER CORPORATION 662 19.1.3.1 Business overview 662 19.1.3.2 Products & services offered 663 19.1.3.3 Recent developments 665 19.1.3.3.1 Product launches 665 19.1.3.3.2 Deals 666 19.1.3.3.3 Expansions 666 19.1.3.4 MnM view 667 19.1.3.4.1 Key strengths 667 19.1.3.4.2 Strategic choices 667 19.1.3.4.3 Weaknesses and competitive threats 667 19.1.4 AGILENT TECHNOLOGIES, INC. 668 19.1.4.1 Business overview 668 19.1.4.2 Products & services offered 669 19.1.4.3 Recent developments 672 19.1.4.3.1 Product launches 672 19.1.4.3.2 Deals 672 19.1.4.4 MnM view 672 19.1.4.4.1 Key strengths 672 19.1.4.4.2 Strategic choices 672 19.1.4.4.3 Weaknesses and competitive threats 673 19.1.5 SARTORIUS AG 674 19.1.5.1 Business overview 674 19.1.5.2 Products & services offered 675 19.1.5.3 Recent developments 676 19.1.5.3.1 Deals 676 19.1.5.3.2 Expansions 676 19.1.5.4 MnM view 677 19.1.5.4.1 Key strength 677 19.1.5.4.2 Strategic choices 677 19.1.5.4.3 Weaknesses and competitive threats 677 19.1.6 GENSCRIPT 678 19.1.6.1 Business overview 678 19.1.6.2 Products & services offered 679 19.1.6.3 Recent developments 680 19.1.6.3.1 Product/Service launches 680 19.1.7 TAKARA BIO INC. 681 19.1.7.1 Business overview 681 19.1.7.2 Products & services offered 682 19.1.7.3 Recent developments 684 19.1.7.3.1 Expansions 684 19.1.8 BIO-RAD LABORATORIES, INC. 685 19.1.8.1 Business overview 685 19.1.8.2 Products & services offered 686 19.1.8.3 Recent developments 688 19.1.8.3.1 Product launches 688 19.1.8.3.2 Deals 688   19.1.9 QIAGEN 689 19.1.9.1 Business overview 689 19.1.9.2 Products & services offered 690 19.1.9.3 Recent developments 691 19.1.9.3.1 Product launches 691 19.1.9.3.2 Deals 691 19.1.10 CHARLES RIVER LABORATORIES 692 19.1.10.1 Business overview 692 19.1.10.2 Products & services offered 693 19.1.10.3 Recent developments 694 19.1.10.3.1 Product/Service launches 694 19.1.11 CORNING INCORPORATED 695 19.1.11.1 Business overview 695 19.1.11.2 Products & services offered 696 19.1.11.3 Recent developments 698 19.1.11.3.1 Product launches 698 19.1.12 LONZA 699 19.1.12.1 Business overview 699 19.1.12.2 Products & services offered 700 19.1.12.3 Recent developments 702 19.1.12.3.1 Product launches 702 19.1.12.3.2 Deals 702 19.1.13 FUJIFILM HOLDINGS CORPORATION 703 19.1.13.1 Business overview 703 19.1.13.2 Products & services offered 704 19.1.13.3 Recent developments 706 19.1.13.3.1 Product launches 706 19.1.13.3.2 Expansions 706 19.1.14 SYNGENE INTERNATIONAL LIMITED 707 19.1.14.1 Business overview 707 19.1.14.2 Products & services offered 708 19.1.14.3 Recent developments 708 19.1.14.3.1 Product launches 708 19.1.15 LGC LIMITED 709 19.1.15.1 Business overview 709 19.1.15.2 Products & services offered 710 19.1.16 EUROFINS SCIENTIFIC 712 19.1.16.1 Business overview 712 19.1.16.2 Products & services offered 713 19.1.16.3 Recent developments 714 19.1.16.3.1 Expansions 714   19.1.17 AJINOMOTO CO., INC. 715 19.1.17.1 Business overview 715 19.1.17.2 Products & services offered 716 19.1.17.3 Recent developments 717 19.1.17.3.1 Deals 717 19.2 OTHER PLAYERS 718 19.2.1 PROMEGA CORPORATION 718 19.2.2 SINO BIOLOGICAL, INC. 719 19.2.3 RAYBIOTECH, INC. 720 19.2.4 BIONEER CORPORATION 721 19.2.5 ORIGENE TECHNOLOGIES, INC. 722 19.2.6 NEW ENGLAND BIOLABS 723 19.2.7 ACCURUS BIOSCIENCES 724 19.2.8 ARAGEN LIFE SCIENCES LTD. 725 19.2.9 OXFORD EXPRESSION TECHNOLOGIES LTD 726 19.2.10 PROTEOGENIX INC. 727 19.2.11 ABEOMICS 728 20 RESEARCH METHODOLOGY 729 20.1 RESEARCH DATA 729 20.1.1 SECONDARY DATA 730 20.1.2 PRIMARY DATA 730 20.2 MARKET ESTIMATION METHODOLOGY 732 20.2.1 MARKET SIZE ESTIMATION 732 20.2.2 INSIGHTS OF PRIMARY EXPERTS 734 20.2.3 TOP-DOWN APPROACH 735 20.3 MARKET GROWTH RATE PROJECTIONS 736 20.4 MARKET BREAKDOWN AND DATA TRIANGULATION 738 20.5 RESEARCH ASSUMPTIONS 739 20.6 RESEARCH LIMITATIONS 739 20.7 RISK ANALYSIS 740 21 APPENDIX 741 21.1 DISCUSSION GUIDE 741 21.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 745 21.3 CUSTOMIZATION OPTIONS 747 21.4 RELATED REPORTS 747 21.5 AUTHOR DETAILS 748
圖表清單 List of Tables & Figures
TABLE 1 PROTEIN EXPRESSION MARKET: IMPACT ANALYSIS 81 TABLE 2 PROTEIN EXPRESSION MARKET: PORTER’S FIVE FORCES ANALYSIS 88 TABLE 3 PROTEIN EXPRESSION MARKET: ROLE IN ECOSYSTEM 94 TABLE 4 AVERAGE SELLING PRICE OF PROTEIN EXPRESSION SYSTEMS, BY KEY PLAYER, 2023-2025 (USD) 95 TABLE 5 INDICATIVE SELLING PRICE OF PROTEIN EXPRESSION SYSTEMS, BY REGION, 2025 (USD) 96 TABLE 6 IMPORT DATA FOR MASS SPECTROMETERS UNDER HS CODE (902781), 2022–2023 (USD THOUSAND) 97 TABLE 7 IMPORT VOLUME FOR MASS SPECTROMETERS UNDER HS CODE (902781), 2022–2025, (UNIT/TONS) 98 TABLE 8 EXPORT DATA FOR MASS SPECTROMETERS UNDER HS CODE (902781), 2022–2025, (USD THOUSAND) 98 TABLE 9 EXPORT VOLUME FOR MASS SPECTROMETERS UNDER HS CODE (902781), 2022–2025, (UNIT/TONS) 99 TABLE 10 PROTEIN EXPRESSION MARKET: KEY CONFERENCES & EVENTS, 2026–2027 100 TABLE 11 US-ADJUSTED RECIPROCAL TARIFF RATES 103 TABLE 12 INDICATIVE LIST OF PATENTS IN PROTEIN EXPRESSION MARKET, 2024 112 TABLE 13 CASE STUDIES OF AI IMPLEMENTATION IN PROTEIN EXPRESSION MARKET 115 TABLE 14 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN PROTEIN EXPRESSION MARKET 116 TABLE 15 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 118 TABLE 16 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 118 TABLE 17 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 119 TABLE 18 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 120 TABLE 19 COUNTRY-WISE REGULATORY SCENARIO FOR PROTEIN EXPRESSION PRODUCT & SERVICE PROVIDERS 121 TABLE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING (%) 126 TABLE 21 KEY BUYING CRITERIA, BY END USER 127 TABLE 22 PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION) 131 TABLE 23 PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 132 TABLE 24 PROTEIN EXPRESSION PRODUCTS MARKET, BY REGION, 2024–2031 (USD MILLION) 132 TABLE 25 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 132 TABLE 26 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 133 TABLE 27 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 133 TABLE 28 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 134 TABLE 29 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET, BY REGION, 2024–2031 (USD MILLION) 134 TABLE 30 GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 134 TABLE 31 PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 135 TABLE 32 PROTEIN EXPRESSION REAGENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 136 TABLE 33 NORTH AMERICA: PROTEIN EXPRESSION REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 136 TABLE 34 EUROPE: PROTEIN EXPRESSION REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 137 TABLE 35 ASIA PACIFIC: PROTEIN EXPRESSION REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 137 TABLE 36 LATIN AMERICA: PROTEIN EXPRESSION REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 138 TABLE 37 MIDDLE EAST: PROTEIN EXPRESSION REAGENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 138 TABLE 38 GCC COUNTRIES: PROTEIN EXPRESSION REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 138 TABLE 39 CULTURE MEDIA & SUPPLEMENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 139 TABLE 40 NORTH AMERICA: CULTURE MEDIA & SUPPLEMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 139 TABLE 41 EUROPE: CULTURE MEDIA & SUPPLEMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 140 TABLE 42 ASIA PACIFIC: CULTURE MEDIA & SUPPLEMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 140 TABLE 43 LATIN AMERICA: CULTURE MEDIA & SUPPLEMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 141 TABLE 44 MIDDLE EAST: CULTURE MEDIA & SUPPLEMENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 141 TABLE 45 GCC COUNTRIES: CULTURE MEDIA & SUPPLEMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 141 TABLE 46 EXPRESSION VECTORS & PLASMIDS MARKET, BY REGION, 2024–2031 (USD MILLION) 142 TABLE 47 NORTH AMERICA: EXPRESSION VECTORS & PLASMIDS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 143 TABLE 48 EUROPE: EXPRESSION VECTORS & PLASMIDS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 143 TABLE 49 ASIA PACIFIC: EXPRESSION VECTORS & PLASMIDS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 144 TABLE 50 LATIN AMERICA: EXPRESSION VECTORS & PLASMIDS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 144 TABLE 51 MIDDLE EAST: EXPRESSION VECTORS & PLASMIDS MARKET, BY REGION, 2024–2031 (USD MILLION) 144 TABLE 52 GCC COUNTRIES: EXPRESSION VECTORS & PLASMIDS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 145 TABLE 53 TRANSDUCTION & TRANSFECTION REAGENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 145 TABLE 54 NORTH AMERICA: TRANSDUCTION & TRANSFECTION REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 146 TABLE 55 EUROPE: TRANSDUCTION & TRANSFECTION REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 146 TABLE 56 ASIA PACIFIC: TRANSDUCTION & TRANSFECTION REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 147 TABLE 57 LATIN AMERICA: TRANSDUCTION & TRANSFECTION REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 147 TABLE 58 MIDDLE EAST: TRANSDUCTION & TRANSFECTION REAGENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 147 TABLE 59 GCC COUNTRIES: TRANSDUCTION & TRANSFECTION REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 148 TABLE 60 COMPETENT CELLS MARKET, BY REGION, 2024–2031 (USD MILLION) 148 TABLE 61 NORTH AMERICA: COMPETENT CELLS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 149 TABLE 62 EUROPE: COMPETENT CELLS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 149 TABLE 63 ASIA PACIFIC: COMPETENT CELLS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 149 TABLE 64 LATIN AMERICA: COMPETENT CELLS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 150 TABLE 65 MIDDLE EAST: COMPETENT CELLS MARKET, BY REGION, 2024–2031 (USD MILLION) 150 TABLE 66 GCC COUNTRIES: COMPETENT CELLS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 150 TABLE 67 OTHER PROTEIN EXPRESSION REAGENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 151 TABLE 68 NORTH AMERICA: OTHER PROTEIN EXPRESSION REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 151 TABLE 69 EUROPE: OTHER PROTEIN EXPRESSION REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 152 TABLE 70 ASIA PACIFIC: OTHER PROTEIN EXPRESSION REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 152 TABLE 71 LATIN AMERICA: OTHER PROTEIN EXPRESSION REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 153 TABLE 72 MIDDLE EAST: OTHER PROTEIN EXPRESSION REAGENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 153 TABLE 73 GCC COUNTRIES: OTHER PROTEIN EXPRESSION REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 153 TABLE 74 PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 154 TABLE 75 PROTEIN EXPRESSION INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 154 TABLE 76 NORTH AMERICA: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 155 TABLE 77 EUROPE: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 155 TABLE 78 ASIA PACIFIC: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 156 TABLE 79 LATIN AMERICA: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 156 TABLE 80 MIDDLE EAST: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 156 TABLE 81 GCC COUNTRIES: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 157 TABLE 82 PROTEIN EXPRESSION PRODUCTS MARKET FOR BIOREACTORS & FERMENTERS, BY REGION, 2024–2031 (USD MILLION) 157 TABLE 83 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR BIOREACTORS & FERMENTERS, BY COUNTRY, 2024–2031 (USD MILLION) 158 TABLE 84 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR BIOREACTORS & FERMENTERS, BY COUNTRY, 2024–2031 (USD MILLION) 158 TABLE 85 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR BIOREACTORS & FERMENTERS, BY COUNTRY, 2024–2031 (USD MILLION) 159 TABLE 86 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR BIOREACTORS & FERMENTERS, BY COUNTRY, 2024–2031 (USD MILLION) 159 TABLE 87 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR BIOREACTORS & FERMENTERS, BY REGION, 2024–2031 (USD MILLION) 159 TABLE 88 GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET FOR BIOREACTORS & FERMENTERS, BY COUNTRY, 2024–2031 (USD MILLION) 160 TABLE 89 CHROMATOGRAPHY SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 161 TABLE 90 NORTH AMERICA: CHROMATOGRAPHY SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 161 TABLE 91 EUROPE: CHROMATOGRAPHY SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 162 TABLE 92 ASIA PACIFIC: CHROMATOGRAPHY SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 162 TABLE 93 LATIN AMERICA: CHROMATOGRAPHY SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 163 TABLE 94 MIDDLE EAST: CHROMATOGRAPHY SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 163 TABLE 95 GCC COUNTRIES: CHROMATOGRAPHY SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 163 TABLE 96 ANALYTICAL INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 164 TABLE 97 NORTH AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 164 TABLE 98 EUROPE: ANALYTICAL INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 165 TABLE 99 ASIA PACIFIC: ANALYTICAL INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 165 TABLE 100 LATIN AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 166 TABLE 101 MIDDLE EAST: ANALYTICAL INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 166 TABLE 102 GCC COUNTRIES: ANALYTICAL INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 166 TABLE 103 LIQUID HANDLING & AUTOMATED SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 167 TABLE 104 NORTH AMERICA: LIQUID HANDLING & AUTOMATED SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 168 TABLE 105 EUROPE: LIQUID HANDLING & AUTOMATED SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 168 TABLE 106 ASIA PACIFIC: LIQUID HANDLING & AUTOMATED SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 169 TABLE 107 LATIN AMERICA: LIQUID HANDLING & AUTOMATED SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 169 TABLE 108 MIDDLE EAST: LIQUID HANDLING & AUTOMATED SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 169 TABLE 109 GCC COUNTRIES: LIQUID HANDLING & AUTOMATED SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 170 TABLE 110 FILTRATION SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 170 TABLE 111 NORTH AMERICA: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 171 TABLE 112 EUROPE: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 171 TABLE 113 ASIA PACIFIC: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 172 TABLE 114 LATIN AMERICA: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 172 TABLE 115 MIDDLE EAST: FILTRATION SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 172 TABLE 116 GCC COUNTRIES: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 173 TABLE 117 OTHER PROTEIN EXPRESSION INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 173 TABLE 118 NORTH AMERICA: OTHER PROTEIN EXPRESSION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 174 TABLE 119 EUROPE: OTHER PROTEIN EXPRESSION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 174 TABLE 120 ASIA PACIFIC: OTHER PROTEIN EXPRESSION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 175 TABLE 121 LATIN AMERICA: OTHER PROTEIN EXPRESSION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 175 TABLE 122 MIDDLE EAST: OTHER PROTEIN EXPRESSION INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 175 TABLE 123 GCC COUNTRIES: OTHER PROTEIN EXPRESSION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 176 TABLE 124 PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 176 TABLE 125 PROTEIN EXPRESSION CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION) 177 TABLE 126 NORTH AMERICA: PROTEIN EXPRESSION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 177 TABLE 127 EUROPE: PROTEIN EXPRESSION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 178 TABLE 128 ASIA PACIFIC: PROTEIN EXPRESSION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 178 TABLE 129 LATIN AMERICA: PROTEIN EXPRESSION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 179 TABLE 130 MIDDLE EAST: PROTEIN EXPRESSION CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION) 179 TABLE 131 GCC COUNTRIES: PROTEIN EXPRESSION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 179 TABLE 132 CHROMATOGRAPHY & PURIFICATION CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION) 180 TABLE 133 NORTH AMERICA: CHROMATOGRAPHY & PURIFICATION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 180 TABLE 134 EUROPE: CHROMATOGRAPHY & PURIFICATION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 181 TABLE 135 ASIA PACIFIC: CHROMATOGRAPHY & PURIFICATION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 181 TABLE 136 LATIN AMERICA: CHROMATOGRAPHY & PURIFICATION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 182 TABLE 137 MIDDLE EAST: CHROMATOGRAPHY & PURIFICATION CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION) 182 TABLE 138 GCC COUNTRIES: CHROMATOGRAPHY & PURIFICATION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 182 TABLE 139 FILTRATION & SEPARATION CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION) 183 TABLE 140 NORTH AMERICA: FILTRATION & SEPARATION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 183 TABLE 141 EUROPE: FILTRATION & SEPARATION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 184 TABLE 142 ASIA PACIFIC: FILTRATION & SEPARATION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 184 TABLE 143 LATIN AMERICA: FILTRATION & SEPARATION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 185 TABLE 144 MIDDLE EAST: FILTRATION & SEPARATION CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION) 185 TABLE 145 GCC COUNTRIES: FILTRATION & SEPARATION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 185 TABLE 146 OTHER PROTEIN EXPRESSION CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION) 186 TABLE 147 NORTH AMERICA: OTHER PROTEIN EXPRESSION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 186 TABLE 148 EUROPE: OTHER PROTEIN EXPRESSION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 187 TABLE 149 ASIA PACIFIC: OTHER PROTEIN EXPRESSION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 187 TABLE 150 LATIN AMERICA: OTHER PROTEIN EXPRESSION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 188 TABLE 151 MIDDLE EAST: OTHER PROTEIN EXPRESSION CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION) 188 TABLE 152 GCC COUNTRIES: OTHER PROTEIN EXPRESSION CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 188 TABLE 153 PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 189 TABLE 154 PROTEIN EXPRESSION KITS MARKET, BY REGION, 2024–2031 (USD MILLION) 189 TABLE 155 NORTH AMERICA: PROTEIN EXPRESSION KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 190 TABLE 156 EUROPE: PROTEIN EXPRESSION KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 190 TABLE 157 ASIA PACIFIC: PROTEIN EXPRESSION KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 191 TABLE 158 LATIN AMERICA: PROTEIN EXPRESSION KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 191 TABLE 159 MIDDLE EAST: PROTEIN EXPRESSION KITS MARKET, BY REGION, 2024–2031 (USD MILLION) 191 TABLE 160 GCC COUNTRIES: PROTEIN EXPRESSION KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 192 TABLE 161 EXPRESSION KITS MARKET, BY REGION, 2024–2031 (USD MILLION) 192 TABLE 162 NORTH AMERICA: EXPRESSION KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 193 TABLE 163 EUROPE: EXPRESSION KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 193 TABLE 164 ASIA PACIFIC: EXPRESSION KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 193 TABLE 165 LATIN AMERICA: EXPRESSION KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 194 TABLE 166 MIDDLE EAST: EXPRESSION KITS MARKET, BY REGION, 2024–2031 (USD MILLION) 194 TABLE 167 GCC COUNTRIES: EXPRESSION KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 194 TABLE 168 CLONING & MUTAGENESIS KITS MARKET, BY REGION, 2024–2031 (USD MILLION) 195 TABLE 169 NORTH AMERICA: CLONING & MUTAGENESIS KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 195 TABLE 170 EUROPE: CLONING & MUTAGENESIS KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 196 TABLE 171 ASIA PACIFIC: CLONING & MUTAGENESIS KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 196 TABLE 172 LATIN AMERICA: CLONING & MUTAGENESIS KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 197 TABLE 173 MIDDLE EAST: CLONING & MUTAGENESIS KITS MARKET, BY REGION, 2024–2031 (USD MILLION) 197 TABLE 174 GCC COUNTRIES: CLONING & MUTAGENESIS KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 197 TABLE 175 OTHER PROTEIN EXPRESSION KITS MARKET, BY REGION, 2024–2031 (USD MILLION) 198 TABLE 176 NORTH AMERICA: OTHER PROTEIN EXPRESSION KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 198 TABLE 177 EUROPE: OTHER PROTEIN EXPRESSION KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 199 TABLE 178 ASIA PACIFIC: OTHER PROTEIN EXPRESSION KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 199 TABLE 179 LATIN AMERICA: OTHER PROTEIN EXPRESSION KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 200 TABLE 180 MIDDLE EAST: OTHER PROTEIN EXPRESSION KITS MARKET, BY REGION, 2024–2031 (USD MILLION) 200 TABLE 181 GCC COUNTRIES: OTHER PROTEIN EXPRESSION KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 200 TABLE 182 PROTEIN EXPRESSION SOFTWARE MARKET, BY REGION, 2024–2031 (USD MILLION) 201 TABLE 183 NORTH AMERICA: PROTEIN EXPRESSION SOFTWARE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 201 TABLE 184 EUROPE: PROTEIN EXPRESSION SOFTWARE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 202 TABLE 185 ASIA PACIFIC: PROTEIN EXPRESSION SOFTWARE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 202 TABLE 186 LATIN AMERICA: PROTEIN EXPRESSION SOFTWARE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 203 TABLE 187 MIDDLE EAST: PROTEIN EXPRESSION SOFTWARE MARKET, BY REGION, 2024–2031 (USD MILLION) 203 TABLE 188 GCC COUNTRIES: PROTEIN EXPRESSION SOFTWARE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 203 TABLE 189 PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 204 TABLE 190 PROTEIN EXPRESSION SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 205 TABLE 191 NORTH AMERICA: PROTEIN EXPRESSION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 205 TABLE 192 EUROPE: PROTEIN EXPRESSION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 206 TABLE 193 ASIA PACIFIC: PROTEIN EXPRESSION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 206 TABLE 194 LATIN AMERICA: PROTEIN EXPRESSION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 207 TABLE 195 MIDDLE EAST: PROTEIN EXPRESSION SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 207 TABLE 196 GCC COUNTRIES: PROTEIN EXPRESSION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 207 TABLE 197 CUSTOM PROTEIN EXPRESSION SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 208 TABLE 198 NORTH AMERICA: CUSTOM PROTEIN EXPRESSION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 208 TABLE 199 EUROPE: CUSTOM PROTEIN EXPRESSION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 209 TABLE 200 ASIA PACIFIC: CUSTOM PROTEIN EXPRESSION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 209 TABLE 201 LATIN AMERICA: CUSTOM PROTEIN EXPRESSION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 210 TABLE 202 MIDDLE EAST: CUSTOM PROTEIN EXPRESSION SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 210 TABLE 203 GCC COUNTRIES: CUSTOM PROTEIN EXPRESSION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 210 TABLE 204 GENE SYNTHESIS & CLONING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 211 TABLE 205 NORTH AMERICA: GENE SYNTHESIS & CLONING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 211 TABLE 206 EUROPE: GENE SYNTHESIS & CLONING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 212 TABLE 207 ASIA PACIFIC: GENE SYNTHESIS & CLONING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 212 TABLE 208 LATIN AMERICA: GENE SYNTHESIS & CLONING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 213 TABLE 209 MIDDLE EAST: GENE SYNTHESIS & CLONING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 213 TABLE 210 GCC COUNTRIES: GENE SYNTHESIS & CLONING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 213 TABLE 211 CELL LINE DEVELOPMENT SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 214 TABLE 212 NORTH AMERICA: CELL LINE DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 214 TABLE 213 EUROPE: CELL LINE DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 215 TABLE 214 ASIA PACIFIC: CELL LINE DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 215 TABLE 215 LATIN AMERICA: CELL LINE DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 216 TABLE 216 MIDDLE EAST: CELL LINE DEVELOPMENT SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 216 TABLE 217 GCC COUNTRIES: CELL LINE DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 216 TABLE 218 PROCESS DEVELOPMENT & SCALE-UP SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 217 TABLE 219 NORTH AMERICA: PROCESS DEVELOPMENT & SCALE-UP SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 217 TABLE 220 EUROPE: PROCESS DEVELOPMENT & SCALE-UP SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 218 TABLE 221 ASIA PACIFIC: PROCESS DEVELOPMENT & SCALE-UP SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 218 TABLE 222 LATIN AMERICA: PROCESS DEVELOPMENT & SCALE-UP SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 219 TABLE 223 MIDDLE EAST: PROCESS DEVELOPMENT & SCALE-UP SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 219 TABLE 224 GCC COUNTRIES: PROCESS DEVELOPMENT & SCALE-UP SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 219 TABLE 225 PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION) 221 TABLE 226 PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 222 TABLE 227 PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 222 TABLE 228 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 223 TABLE 229 EUROPE: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 223 TABLE 230 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 224 TABLE 231 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 224 TABLE 232 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 224 TABLE 233 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 225 TABLE 234 PROTEIN EXPRESSION MARKET FOR CHO CELL SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 226 TABLE 235 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR CHO CELL SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 226 TABLE 236 EUROPE: PROTEIN EXPRESSION MARKET FOR CHO CELL SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 227 TABLE 237 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR CHO CELL SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 227 TABLE 238 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR CHO CELL SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 228 TABLE 239 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR CHO CELL SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 228 TABLE 240 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR CHO CELL SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 228 TABLE 241 PROTEIN EXPRESSION MARKET FOR HEK 293 CELL SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 229 TABLE 242 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR HEK 293 CELL SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 230 TABLE 243 EUROPE: PROTEIN EXPRESSION MARKET FOR HEK 293 CELL SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 230 TABLE 244 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR HEK 293 CELL SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 231 TABLE 245 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR HEK 293 CELL SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 231 TABLE 246 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR HEK 293 CELL SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 231 TABLE 247 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR HEK 293 CELL SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 232 TABLE 248 PROTEIN EXPRESSION MARKET FOR OTHER MAMMALIAN CELL EXPRESSION SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 232 TABLE 249 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 233 TABLE 250 EUROPE: PROTEIN EXPRESSION MARKET FOR OTHER MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 233 TABLE 251 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR OTHER MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 234 TABLE 252 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 234 TABLE 253 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR OTHER MAMMALIAN CELL EXPRESSION SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 234 TABLE 254 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR OTHER MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 235 TABLE 255 PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 235 TABLE 256 PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 236 TABLE 257 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 236 TABLE 258 EUROPE: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 237 TABLE 259 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 237 TABLE 260 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 238 TABLE 261 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 238 TABLE 262 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 238 TABLE 263 PROTEIN EXPRESSION MARKET FOR E. COLI SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 239 TABLE 264 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR E. COLI SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 240 TABLE 265 EUROPE: PROTEIN EXPRESSION MARKET FOR E. COLI SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 240 TABLE 266 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR E. COLI SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 241 TABLE 267 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR E. COLI SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 241 TABLE 268 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR E. COLI SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 241 TABLE 269 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR E. COLI SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 242 TABLE 270 PROTEIN EXPRESSION MARKET FOR BACILLUS SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 243 TABLE 271 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR BACILLUS SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 243 TABLE 272 EUROPE: PROTEIN EXPRESSION MARKET FOR BACILLUS SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 244 TABLE 273 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR BACILLUS SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 244 TABLE 274 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR BACILLUS SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 245 TABLE 275 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR BACILLUS SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 245 TABLE 276 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR BACILLUS SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 245 TABLE 277 PROTEIN EXPRESSION MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 246 TABLE 278 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 246 TABLE 279 EUROPE: PROTEIN EXPRESSION MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 247 TABLE 280 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 247 TABLE 281 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 248 TABLE 282 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 248 TABLE 283 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 248 TABLE 284 PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 249 TABLE 285 PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 249 TABLE 286 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 250 TABLE 287 EUROPE: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 250 TABLE 288 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 251 TABLE 289 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 251 TABLE 290 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 251 TABLE 291 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 252 TABLE 292 PROTEIN EXPRESSION MARKET FOR BACULOVIRUS SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 253 TABLE 293 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR BACULOVIRUS SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 253 TABLE 294 EUROPE: PROTEIN EXPRESSION MARKET FOR BACULOVIRUS SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 254 TABLE 295 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR BACULOVIRUS SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 254 TABLE 296 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR BACULOVIRUS SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 255 TABLE 297 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR BACULOVIRUS SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 255 TABLE 298 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR BACULOVIRUS SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 255 TABLE 299 PROTEIN EXPRESSION MARKET FOR OTHER INSECT CELL SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 256 TABLE 300 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER INSECT CELL SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 256 TABLE 301 EUROPE: PROTEIN EXPRESSION MARKET FOR OTHER INSECT CELL SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 257 TABLE 302 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR OTHER INSECT CELL SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 257 TABLE 303 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER INSECT CELL SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 258 TABLE 304 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR OTHER INSECT CELL SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 258 TABLE 305 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR OTHER INSECT CELL SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 258 TABLE 306 PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 259 TABLE 307 PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 260 TABLE 308 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 260 TABLE 309 EUROPE: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 261 TABLE 310 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 261 TABLE 311 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 262 TABLE 312 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 262 TABLE 313 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 262 TABLE 314 PROTEIN EXPRESSION MARKET FOR PICHIA SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 263 TABLE 315 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR PICHIA SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 264 TABLE 316 EUROPE: PROTEIN EXPRESSION MARKET FOR PICHIA SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 264 TABLE 317 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR PICHIA SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 265 TABLE 318 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR PICHIA SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 265 TABLE 319 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR PICHIA SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 265 TABLE 320 GCC COUNTRIES: PROTEIN EXPRESSION MARKET PICHIA SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 266 TABLE 321 PROTEIN EXPRESSION MARKET FOR SACCHAROMYCES SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 266 TABLE 322 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR SACCHAROMYCES SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 267 TABLE 323 EUROPE: PROTEIN EXPRESSION MARKET FOR SACCHAROMYCES SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 267 TABLE 324 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR SACCHAROMYCES SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 268 TABLE 325 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR SACCHAROMYCES SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 268 TABLE 326 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR SACCHAROMYCES SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 268 TABLE 327 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR SACCHAROMYCES SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 269 TABLE 328 PROTEIN EXPRESSION MARKET FOR OTHER YEAST EXPRESSION SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 269 TABLE 329 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 270 TABLE 330 EUROPE: PROTEIN EXPRESSION MARKET FOR OTHER YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 270 TABLE 331 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR OTHER YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 271 TABLE 332 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 271 TABLE 333 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR OTHER YEAST EXPRESSION REGION, BY COUNTRY, 2024–2031 (USD MILLION) 271 TABLE 334 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR OTHER YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 272 TABLE 335 PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 272 TABLE 336 PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 273 TABLE 337 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 273 TABLE 338 EUROPE: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 274 TABLE 339 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 274 TABLE 340 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 275 TABLE 341 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 275 TABLE 342 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 275 TABLE 343 PROTEIN EXPRESSION MARKET FOR E. COLI LYSATE-BASED SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 276 TABLE 344 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR E. COLI LYSATE-BASED SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 277 TABLE 345 EUROPE: PROTEIN EXPRESSION MARKET FOR E. COLI LYSATE-BASED SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 277 TABLE 346 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR E. COLI LYSATE-BASED SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 278 TABLE 347 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR E. COLI LYSATE-BASED SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 278 TABLE 348 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR E. COLI LYSATE-BASED SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 278 TABLE 349 GCC COUNTRIES: PROTEIN EXPRESSION MARKET E. COLI LYSATE-BASED SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 279 TABLE 350 PROTEIN EXPRESSION MARKET FOR OTHER CELL-FREE EXPRESSION SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 279 TABLE 351 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 280 TABLE 352 EUROPE: PROTEIN EXPRESSION MARKET FOR OTHER CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 280 TABLE 353 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR OTHER CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 281 TABLE 354 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 281 TABLE 355 MIDDLE EAST: PROTEIN EXPRESSION MARKET OTHER CELL-FREE EXPRESSION SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 281 TABLE 356 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR OTHER CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 282 TABLE 357 PROTEIN EXPRESSION MARKET FOR ALGAL & PLANT-BASED EXPRESSION SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 283 TABLE 358 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR ALGAL & PLANT-BASED EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 283 TABLE 359 EUROPE: PROTEIN EXPRESSION MARKET FOR ALGAL & PLANT-BASED EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 284 TABLE 360 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR ALGAL & PLANT-BASED EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 284 TABLE 361 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR ALGAL & PLANT-BASED EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 285 TABLE 362 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR ALGAL & PLANT-BASED EXPRESSION SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 285 TABLE 363 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR ALGAL & PLANT-BASED EXPRESSION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 285 TABLE 364 PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 287 TABLE 365 PROTEIN EXPRESSION MARKET FOR CLONING & TRANSFECTION, BY REGION, 2024–2031 (USD MILLION) 288 TABLE 366 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR CLONING & TRANSFECTION, BY COUNTRY, 2024–2031 (USD MILLION) 288 TABLE 367 EUROPE: PROTEIN EXPRESSION MARKET FOR CLONING & TRANSFECTION, BY COUNTRY, 2024–2031 (USD MILLION) 289 TABLE 368 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR CLONING & TRANSFECTION, BY COUNTRY, 2024–2031 (USD MILLION) 289 TABLE 369 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR CLONING & TRANSFECTION, BY COUNTRY, 2024–2031 (USD MILLION) 290 TABLE 370 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR CLONING & TRANSFECTION, BY REGION, 2024–2031 (USD MILLION) 290 TABLE 371 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR CLONING & TRANSFECTION, BY COUNTRY, 2024–2031 (USD MILLION) 290 TABLE 372 PROTEIN EXPRESSION MARKET FOR TRANSCRIPTION, TRANSLATION, AND POST-TRANSLATIONAL MODIFICATION, BY REGION, 2024–2031 (USD MILLION) 291 TABLE 373 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR TRANSCRIPTION, TRANSLATION, AND POST-TRANSLATIONAL MODIFICATION, BY COUNTRY, 2024–2031 (USD MILLION) 292 TABLE 374 EUROPE: PROTEIN EXPRESSION MARKET FOR TRANSCRIPTION, TRANSLATION, AND POST-TRANSLATIONAL MODIFICATION, BY COUNTRY, 2024–2031 (USD MILLION) 292 TABLE 375 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR TRANSCRIPTION, TRANSLATION, AND POST-TRANSLATIONAL MODIFICATION, BY COUNTRY, 2024–2031 (USD MILLION) 293 TABLE 376 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR TRANSCRIPTION, TRANSLATION, AND POST-TRANSLATIONAL MODIFICATION, BY COUNTRY, 2024–2031 (USD MILLION) 293 TABLE 377 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR TRANSCRIPTION, TRANSLATION, AND POST-TRANSLATIONAL MODIFICATION, BY REGION, 2024–2031 (USD MILLION) 293 TABLE 378 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR TRANSCRIPTION, TRANSLATION, AND POST-TRANSLATIONAL MODIFICATION, BY COUNTRY, 2024–2031 (USD MILLION) 294 TABLE 379 PROTEIN EXPRESSION MARKET FOR EXTRACTION, PURIFICATION, AND CHARACTERIZATION, BY REGION, 2024–2031 (USD MILLION) 295 TABLE 380 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR EXTRACTION, PURIFICATION, AND CHARACTERIZATION, BY COUNTRY, 2024–2031 (USD MILLION) 295 TABLE 381 EUROPE: PROTEIN EXPRESSION MARKET FOR EXTRACTION, PURIFICATION, AND CHARACTERIZATION, BY COUNTRY, 2024–2031 (USD MILLION) 296 TABLE 382 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR EXTRACTION, PURIFICATION, AND CHARACTERIZATION, BY COUNTRY, 2024–2031 (USD MILLION) 296 TABLE 383 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR EXTRACTION, PURIFICATION, AND CHARACTERIZATION, BY COUNTRY, 2024–2031 (USD MILLION) 297 TABLE 384 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR EXTRACTION, PURIFICATION, AND CHARACTERIZATION, BY REGION, 2024–2031 (USD MILLION) 297 TABLE 385 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR EXTRACTION, PURIFICATION, AND CHARACTERIZATION, BY COUNTRY, 2024–2031 (USD MILLION) 297 TABLE 386 PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION) 299 TABLE 387 PROTEIN EXPRESSION PRODUCTS MARKET FOR DISCOVERY & RESEARCH SCALE, BY REGION, 2024–2031 (USD MILLION) 300 TABLE 388 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR DISCOVERY & RESEARCH SCALE, BY COUNTRY, 2024–2031 (USD MILLION) 300 TABLE 389 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR DISCOVERY & RESEARCH SCALE, BY COUNTRY, 2024–2031 (USD MILLION) 301 TABLE 390 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR DISCOVERY & RESEARCH SCALE, BY COUNTRY, 2024–2031 (USD MILLION) 301 TABLE 391 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR DISCOVERY & RESEARCH SCALE, BY COUNTRY, 2024–2031 (USD MILLION) 302 TABLE 392 MIDDLE EAST: PROTEIN PRODUCTS EXPRESSION MARKET FOR DISCOVERY & RESEARCH SCALE, BY REGION, 2024–2031 (USD MILLION) 302 TABLE 393 GCC COUNTRIES: PROTEIN PRODUCTS EXPRESSION MARKET FOR DISCOVERY & RESEARCH SCALE, BY COUNTRY, 2024–2031 (USD MILLION) 302 TABLE 394 PROTEIN EXPRESSION PRODUCTS MARKET FOR PRECLINICAL & CHARACTERIZATION SCALE, BY REGION, 2024–2031 (USD MILLION) 303 TABLE 395 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR PRECLINICAL & CHARACTERIZATION SCALE, BY COUNTRY, 2024–2031 (USD MILLION) 304 TABLE 396 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR PRECLINICAL & CHARACTERIZATION SCALE, BY COUNTRY, 2024–2031 (USD MILLION) 304 TABLE 397 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR PRECLINICAL & CHARACTERIZATION SCALE, BY COUNTRY, 2024–2031 (USD MILLION) 305 TABLE 398 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR PRECLINICAL & CHARACTERIZATION SCALE, BY COUNTRY, 2024–2031 (USD MILLION) 305 TABLE 399 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR PRECLINICAL & CHARACTERIZATION SCALE, BY REGION, 2024–2031 (USD MILLION) 305 TABLE 400 GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET FOR PRECLINICAL & CHARACTERIZATION SCALE, BY COUNTRY, 2024–2031 (USD MILLION) 306 TABLE 401 PROTEIN EXPRESSION PRODUCTS MARKET FOR PROCESS DEVELOPMENT & PILOT SCALE, BY REGION, 2024–2031 (USD MILLION) 307 TABLE 402 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR PROCESS DEVELOPMENT & PILOT SCALE, BY COUNTRY, 2024–2031 (USD MILLION) 307 TABLE 403 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR PROCESS DEVELOPMENT & PILOT SCALE, BY COUNTRY, 2024–2031 (USD MILLION) 308 TABLE 404 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR PROCESS DEVELOPMENT & PILOT SCALE, BY COUNTRY, 2024–2031 (USD MILLION) 308 TABLE 405 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR PROCESS DEVELOPMENT & PILOT SCALE, BY COUNTRY, 2024–2031 (USD MILLION) 309 TABLE 406 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR PROCESS DEVELOPMENT & PILOT SCALE, BY REGION, 2024–2031 (USD MILLION) 309 TABLE 407 GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET FOR PROCESS DEVELOPMENT & PILOT SCALE, BY COUNTRY, 2024–2031 (USD MILLION) 309 TABLE 408 PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION) 311 TABLE 409 PROTEIN EXPRESSION PRODUCTS MARKET FOR MONOCLONAL ANTIBODIES & DERIVATIVES, BY REGION, 2024–2031 (USD MILLION) 312 TABLE 410 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR MONOCLONAL ANTIBODIES & DERIVATIVES, BY COUNTRY, 2024–2031 (USD MILLION) 312 TABLE 411 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR MONOCLONAL ANTIBODIES & DERIVATIVES, BY COUNTRY, 2024–2031 (USD MILLION) 313 TABLE 412 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR MONOCLONAL ANTIBODIES & DERIVATIVES, BY COUNTRY, 2024–2031 (USD MILLION) 313 TABLE 413 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR MONOCLONAL ANTIBODIES & DERIVATIVES, BY COUNTRY, 2024–2031 (USD MILLION) 314 TABLE 414 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR MONOCLONAL ANTIBODIES & DERIVATIVES, BY REGION, 2024–2031 (USD MILLION) 314 TABLE 415 GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET FOR MONOCLONAL ANTIBODIES & DERIVATIVES, BY COUNTRY, 2024–2031 (USD MILLION) 314 TABLE 416 PROTEIN EXPRESSION PRODUCTS MARKET FOR RECOMBINANT THERAPEUTIC PROTEINS, BY REGION, 2024–2031 (USD MILLION) 315 TABLE 417 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR RECOMBINANT THERAPEUTIC PROTEINS, BY COUNTRY, 2024–2031 (USD MILLION) 316 TABLE 418 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR RECOMBINANT THERAPEUTIC PROTEINS, BY COUNTRY, 2024–2031 (USD MILLION) 316 TABLE 419 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR RECOMBINANT THERAPEUTIC PROTEINS, BY COUNTRY, 2024–2031 (USD MILLION) 317 TABLE 420 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR RECOMBINANT THERAPEUTIC PROTEINS, BY COUNTRY, 2024–2031 (USD MILLION) 317 TABLE 421 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR RECOMBINANT THERAPEUTIC PROTEINS, BY REGION, 2024–2031 (USD MILLION) 317 TABLE 422 GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET FOR RECOMBINANT THERAPEUTIC PROTEINS, BY COUNTRY, 2024–2031 (USD MILLION) 318 TABLE 423 PROTEIN EXPRESSION PRODUCTS MARKET FOR VACCINES, BY REGION, 2024–2031 (USD MILLION) 318 TABLE 424 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR VACCINES, BY COUNTRY, 2024–2031 (USD MILLION) 319 TABLE 425 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR VACCINES, BY COUNTRY, 2024–2031 (USD MILLION) 319 TABLE 426 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR VACCINES, BY COUNTRY, 2024–2031 (USD MILLION) 320 TABLE 427 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR VACCINES, BY COUNTRY, 2024–2031 (USD MILLION) 320 TABLE 428 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR VACCINES, BY REGION, 2024–2031 (USD MILLION) 320 TABLE 429 GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET FOR VACCINES, BY COUNTRY, 2024–2031 (USD MILLION) 321 TABLE 430 PROTEIN EXPRESSION PRODUCTS MARKET FOR ENZYMES & CATALYTIC PROTEINS, BY REGION, 2024–2031 (USD MILLION) 321 TABLE 431 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR ENZYMES & CATALYTIC PROTEINS, BY COUNTRY, 2024–2031 (USD MILLION) 322 TABLE 432 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR ENZYMES & CATALYTIC PROTEINS, BY COUNTRY, 2024–2031 (USD MILLION) 322 TABLE 433 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR ENZYMES & CATALYTIC PROTEINS, BY COUNTRY, 2024–2031 (USD MILLION) 323 TABLE 434 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR ENZYMES & CATALYTIC PROTEINS, BY COUNTRY, 2024–2031 (USD MILLION) 323 TABLE 435 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR ENZYMES & CATALYTIC PROTEINS, BY REGION, 2024–2031 (USD MILLION) 323 TABLE 436 GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET FOR ENZYMES & CATALYTIC PROTEINS, BY COUNTRY, 2024–2031 (USD MILLION) 324 TABLE 437 PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER PROTEINS, BY REGION, 2024–2031 (USD MILLION) 324 TABLE 438 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER PROTEINS, BY COUNTRY, 2024–2031 (USD MILLION) 325 TABLE 439 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER PROTEINS, BY COUNTRY, 2024–2031 (USD MILLION) 325 TABLE 440 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER PROTEINS, BY COUNTRY, 2024–2031 (USD MILLION) 326 TABLE 441 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER PROTEINS, BY COUNTRY, 2024–2031 (USD MILLION) 326 TABLE 442 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER PROTEINS, BY REGION, 2024–2031 (USD MILLION) 326 TABLE 443 GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER PROTEINS, BY COUNTRY, 2024–2031 (USD MILLION) 327 TABLE 444 PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 329 TABLE 445 PROTEIN EXPRESSION MARKET FOR THERAPEUTIC APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 330 TABLE 446 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 330 TABLE 447 EUROPE: PROTEIN EXPRESSION MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 331 TABLE 448 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 331 TABLE 449 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 332 TABLE 450 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR THERAPEUTIC APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 332 TABLE 451 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 332 TABLE 452 PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 334 TABLE 453 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 334 TABLE 454 EUROPE: PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 335 TABLE 455 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 335 TABLE 456 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 336 TABLE 457 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 336 TABLE 458 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 336 TABLE 459 LIST OF INDUSTRIAL ENZYMES AND APPLICATIONS 337 TABLE 460 PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 338 TABLE 461 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 339 TABLE 462 EUROPE: PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 339 TABLE 463 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 340 TABLE 464 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 340 TABLE 465 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 340 TABLE 466 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 341 TABLE 467 PROTEIN EXPRESSION MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 342 TABLE 468 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 342 TABLE 469 EUROPE: PROTEIN EXPRESSION MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 343 TABLE 470 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 343 TABLE 471 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 344 TABLE 472 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 344 TABLE 473 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 344 TABLE 474 PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 346 TABLE 475 PROTEIN EXPRESSION PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION) 347 TABLE 476 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 347 TABLE 477 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 348 TABLE 478 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 348 TABLE 479 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 349 TABLE 480 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION) 349 TABLE 481 GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 349 TABLE 482 PROTEIN EXPRESSION PRODUCTS MARKET FOR CROS & CDMOS, BY REGION, 2024–2031 (USD MILLION) 350 TABLE 483 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2024–2031 (USD MILLION) 351 TABLE 484 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2024–2031 (USD MILLION) 351 TABLE 485 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2024–2031 (USD MILLION) 352 TABLE 486 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2024–2031 (USD MILLION) 352 TABLE 487 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR CROS & CDMOS, BY REGION, 2024–2031 (USD MILLION) 352 TABLE 488 GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2024–2031 (USD MILLION) 353 TABLE 489 PROTEIN EXPRESSION PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION) 354 TABLE 490 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 354 TABLE 491 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 355 TABLE 492 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 355 TABLE 493 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 356 TABLE 494 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION) 356 TABLE 495 GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 356 TABLE 496 PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION) 357 TABLE 497 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 358 TABLE 498 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 358 TABLE 499 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 359 TABLE 500 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 359 TABLE 501 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION) 359 TABLE 502 GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 360 TABLE 503 PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 362 TABLE 504 PROTEIN EXPRESSION SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION) 363 TABLE 505 NORTH AMERICA: PROTEIN EXPRESSION SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 363 TABLE 506 EUROPE: PROTEIN EXPRESSION SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 364 TABLE 507 ASIA PACIFIC: PROTEIN EXPRESSION SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 364 TABLE 508 LATIN AMERICA: PROTEIN EXPRESSION SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 365 TABLE 509 MIDDLE EAST: PROTEIN EXPRESSION SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION) 365 TABLE 510 GCC COUNTRIES: PROTEIN EXPRESSION SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 365 TABLE 511 PROTEIN EXPRESSION SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION) 366 TABLE 512 NORTH AMERICA: PROTEIN EXPRESSION SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 367 TABLE 513 EUROPE: PROTEIN EXPRESSION SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 367 TABLE 514 ASIA PACIFIC: PROTEIN EXPRESSION SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 368 TABLE 515 LATIN AMERICA: PROTEIN EXPRESSION SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 368 TABLE 516 MIDDLE EAST: PROTEIN EXPRESSION SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION) 368 TABLE 517 GCC COUNTRIES: PROTEIN EXPRESSION SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 369 TABLE 518 PROTEIN EXPRESSION SERVICES MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION) 369 TABLE 519 NORTH AMERICA: PROTEIN EXPRESSION SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 370 TABLE 520 EUROPE: PROTEIN EXPRESSION SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 370 TABLE 521 ASIA PACIFIC: PROTEIN EXPRESSION SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 371 TABLE 522 LATIN AMERICA: PROTEIN EXPRESSION SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 371 TABLE 523 MIDDLE EAST: PROTEIN EXPRESSION SERVICES MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION) 371 TABLE 524 GCC COUNTRIES: PROTEIN EXPRESSION SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 372 TABLE 525 PROTEIN EXPRESSION MARKET, BY REGION, 2024–2031 (USD MILLION) 374 TABLE 526 NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 375 TABLE 527 NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION) 376 TABLE 528 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 376 TABLE 529 NORTH AMERICA: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 377 TABLE 530 NORTH AMERICA: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 377 TABLE 531 NORTH AMERICA: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 378 TABLE 532 NORTH AMERICA: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 378 TABLE 533 NORTH AMERICA: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 379 TABLE 534 NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 379 TABLE 535 NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION) 380 TABLE 536 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 380 TABLE 537 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 381 TABLE 538 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 381 TABLE 539 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 381 TABLE 540 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 382 TABLE 541 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION) 382 TABLE 542 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION) 383 TABLE 543 NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 383 TABLE 544 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 384 TABLE 545 NORTH AMERICA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 384 TABLE 546 US: NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION) 385 TABLE 547 US: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 385 TABLE 548 US: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 386 TABLE 549 US: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 386 TABLE 550 US: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 387 TABLE 551 US: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 387 TABLE 552 US: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 388 TABLE 553 US: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 388 TABLE 554 US: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION) 389 TABLE 555 US: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 389 TABLE 556 US: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 390 TABLE 557 US: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 390 TABLE 558 US: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 390 TABLE 559 US: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 391 TABLE 560 US: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION) 391 TABLE 561 US: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION) 392 TABLE 562 US: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 392 TABLE 563 US: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 393 TABLE 564 US: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 393 TABLE 565 CANADA: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION) 394 TABLE 566 CANADA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 394 TABLE 567 CANADA: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 395 TABLE 568 CANADA: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 395 TABLE 569 CANADA: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 396 TABLE 570 CANADA: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 396 TABLE 571 CANADA: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 397 TABLE 572 CANADA: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 397 TABLE 573 CANADA: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION) 398 TABLE 574 CANADA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 398 TABLE 575 CANADA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 399 TABLE 576 CANADA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 399 TABLE 577 CANADA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 399 TABLE 578 CANADA: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 400 TABLE 579 CANADA: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION) 400 TABLE 580 CANADA: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION) 401 TABLE 581 CANADA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 401 TABLE 582 CANADA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 402 TABLE 583 CANADA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 402 TABLE 584 EUROPE: PROTEIN EXPRESSION MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 403 TABLE 585 EUROPE: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION) 403 TABLE 586 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 404 TABLE 587 EUROPE: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 404 TABLE 588 EUROPE: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 405 TABLE 589 EUROPE: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 405 TABLE 590 EUROPE: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 406 TABLE 591 EUROPE: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 406 TABLE 592 EUROPE: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 406 TABLE 593 EUROPE: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION) 407 TABLE 594 EUROPE: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 407 TABLE 595 EUROPE: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 408 TABLE 596 EUROPE: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 408 TABLE 597 EUROPE: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 408 TABLE 598 EUROPE: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 409 TABLE 599 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION) 409 TABLE 600 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION) 410 TABLE 601 EUROPE: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 410 TABLE 602 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 411 TABLE 603 EUROPE: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 411 TABLE 604 GERMANY: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION) 412 TABLE 605 GERMANY: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 412 TABLE 606 GERMANY: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 413 TABLE 607 GERMANY: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 413 TABLE 608 GERMANY: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 414 TABLE 609 GERMANY: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 414 TABLE 610 GERMANY: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 415 TABLE 611 GERMANY: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 415 TABLE 612 GERMANY: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION) 416 TABLE 613 GERMANY: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 416 TABLE 614 GERMANY: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 417 TABLE 615 GERMANY: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 417 TABLE 616 GERMANY: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 417 TABLE 617 GERMANY: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 418 TABLE 618 GERMANY: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION) 418 TABLE 619 GERMANY: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION) 419 TABLE 620 GERMANY: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 419 TABLE 621 GERMANY: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 420 TABLE 622 GERMANY: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 420 TABLE 623 UK: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION) 421 TABLE 624 UK: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 421 TABLE 625 UK: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 422 TABLE 626 UK: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 422 TABLE 627 UK: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 423 TABLE 628 UK: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 423 TABLE 629 UK: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 423 TABLE 630 UK: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 424 TABLE 631 UK: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION) 424 TABLE 632 UK: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 425 TABLE 633 UK: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 425 TABLE 634 UK: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 425 TABLE 635 UK: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 426 TABLE 636 UK: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 426 TABLE 637 UK: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION) 426 TABLE 638 UK: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION) 427 TABLE 639 UK: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 427 TABLE 640 UK: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 428 TABLE 641 UK: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 428 TABLE 642 FRANCE: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION) 429 TABLE 643 FRANCE: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 429 TABLE 644 FRANCE: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 430 TABLE 645 FRANCE: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 430 TABLE 646 FRANCE: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 431 TABLE 647 FRANCE: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 431 TABLE 648 FRANCE: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 431 TABLE 649 FRANCE: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 432 TABLE 650 FRANCE: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION) 432 TABLE 651 FRANCE: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 433 TABLE 652 FRANCE: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 433 TABLE 653 FRANCE: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 433 TABLE 654 FRANCE: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 434 TABLE 655 FRANCE: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 434 TABLE 656 FRANCE: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION) 434 TABLE 657 FRANCE: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION) 435 TABLE 658 FRANCE: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 435 TABLE 659 FRANCE: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 436 TABLE 660 FRANCE: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 436 TABLE 661 ITALY: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION) 437 TABLE 662 ITALY: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 437 TABLE 663 ITALY: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 438 TABLE 664 ITALY: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 438 TABLE 665 ITALY: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 439 TABLE 666 ITALY: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 439 TABLE 667 ITALY: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 439 TABLE 668 ITALY: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 440 TABLE 669 ITALY: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION) 440 TABLE 670 ITALY: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 441 TABLE 671 ITALY: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 441 TABLE 672 ITALY: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 441 TABLE 673 ITALY: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 442 TABLE 674 ITALY: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 442 TABLE 675 ITALY: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION) 442 TABLE 676 ITALY: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION) 443 TABLE 677 ITALY: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 443 TABLE 678 ITALY: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 444 TABLE 679 ITALY: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 444 TABLE 680 SPAIN: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION) 445 TABLE 681 SPAIN: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 445 TABLE 682 SPAIN: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 446 TABLE 683 SPAIN: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 446 TABLE 684 SPAIN: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 447 TABLE 685 SPAIN: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 447 TABLE 686 SPAIN: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 447 TABLE 687 SPAIN: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 448 TABLE 688 SPAIN: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION) 448 TABLE 689 SPAIN: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 449 TABLE 690 SPAIN: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 449 TABLE 691 SPAIN: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 449 TABLE 692 SPAIN: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 450 TABLE 693 SPAIN: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 450 TABLE 694 SPAIN: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION) 450 TABLE 695 SPAIN: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION) 451 TABLE 696 SPAIN: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 451 TABLE 697 SPAIN: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 452 TABLE 698 SPAIN: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 452 TABLE 699 NETHERLANDS: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION) 453 TABLE 700 NETHERLANDS: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 453 TABLE 701 NETHERLANDS: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 454 TABLE 702 NETHERLANDS: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 454 TABLE 703 NETHERLANDS: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 455 TABLE 704 NETHERLANDS: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 455 TABLE 705 NETHERLANDS: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 455 TABLE 706 NETHERLANDS: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 456 TABLE 707 NETHERLANDS: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION) 456 TABLE 708 NETHERLANDS: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 457 TABLE 709 NETHERLANDS: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 457 TABLE 710 NETHERLANDS: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 457 TABLE 711 NETHERLANDS: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 458 TABLE 712 NETHERLANDS: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 458 TABLE 713 NETHERLANDS: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION) 458 TABLE 714 NETHERLANDS: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION) 459 TABLE 715 NETHERLANDS: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 459 TABLE 716 NETHERLANDS: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 460 TABLE 717 NETHERLANDS: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 460 TABLE 718 REST OF EUROPE: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION) 461 TABLE 719 REST OF EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 461 TABLE 720 REST OF EUROPE: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 462 TABLE 721 REST OF EUROPE: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 462 TABLE 722 REST OF EUROPE: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 463 TABLE 723 REST OF EUROPE: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 463 TABLE 724 REST OF EUROPE: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 464 TABLE 725 REST OF EUROPE: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 464 TABLE 726 REST OF EUROPE: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION) 465 TABLE 727 REST OF EUROPE: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 465 TABLE 728 REST OF EUROPE: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 466 TABLE 729 REST OF EUROPE: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 466 TABLE 730 REST OF EUROPE: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 466 TABLE 731 REST OF EUROPE: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 467 TABLE 732 REST OF EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION) 467 TABLE 733 REST OF EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION) 468 TABLE 734 REST OF EUROPE: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 468 TABLE 735 REST OF EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 469 TABLE 736 REST OF EUROPE: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 469 TABLE 737 ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 471 TABLE 738 ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION) 472 TABLE 739 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 472 TABLE 740 ASIA PACIFIC: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 472 TABLE 741 ASIA PACIFIC: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 473 TABLE 742 ASIA PACIFIC: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 473 TABLE 743 ASIA PACIFIC: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 474 TABLE 744 ASIA PACIFIC: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 474 TABLE 745 ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 475 TABLE 746 ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION) 475 TABLE 747 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 476 TABLE 748 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 476 TABLE 749 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 476 TABLE 750 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 477 TABLE 751 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 477 TABLE 752 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION) 477 TABLE 753 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION) 478 TABLE 754 ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 478 TABLE 755 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 479 TABLE 756 ASIA PACIFIC: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 479 TABLE 757 CHINA: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION) 480 TABLE 758 CHINA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 480 TABLE 759 CHINA: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 481 TABLE 760 CHINA: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 481 TABLE 761 CHINA: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 482 TABLE 762 CHINA: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 482 TABLE 763 CHINA: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 482 TABLE 764 CHINA: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 483 TABLE 765 CHINA: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION) 483 TABLE 766 CHINA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 484 TABLE 767 CHINA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 484 TABLE 768 CHINA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 484 TABLE 769 CHINA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 485 TABLE 770 CHINA: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 485 TABLE 771 CHINA: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION) 485 TABLE 772 CHINA: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION) 486 TABLE 773 CHINA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 486 TABLE 774 CHINA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 487 TABLE 775 CHINA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 487 TABLE 776 JAPAN: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION) 488 TABLE 777 JAPAN: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 489 TABLE 778 JAPAN: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 489 TABLE 779 JAPAN: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 490 TABLE 780 JAPAN: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 490 TABLE 781 JAPAN: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 490 TABLE 782 JAPAN: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 491 TABLE 783 JAPAN: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 491 TABLE 784 JAPAN: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION) 492 TABLE 785 JAPAN: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 492 TABLE 786 JAPAN: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 493 TABLE 787 JAPAN: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 493 TABLE 788 JAPAN: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 493 TABLE 789 JAPAN: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 494 TABLE 790 JAPAN: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION) 494 TABLE 791 JAPAN: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION) 494 TABLE 792 JAPAN: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 495 TABLE 793 JAPAN: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 495 TABLE 794 JAPAN: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 495 TABLE 795 INDIA: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION) 496 TABLE 796 INDIA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 497 TABLE 797 INDIA: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 497 TABLE 798 INDIA: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 498 TABLE 799 INDIA: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 498 TABLE 800 INDIA: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 498 TABLE 801 INDIA: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 499 TABLE 802 INDIA: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 499 TABLE 803 INDIA: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION) 500 TABLE 804 INDIA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 500 TABLE 805 INDIA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 501 TABLE 806 INDIA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 501 TABLE 807 INDIA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 501 TABLE 808 INDIA: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 502 TABLE 809 INDIA: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION) 502 TABLE 810 INDIA: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION) 502 TABLE 811 INDIA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 503 TABLE 812 INDIA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 503 TABLE 813 INDIA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 503 TABLE 814 AUSTRALIA: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION) 504 TABLE 815 AUSTRALIA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 504 TABLE 816 AUSTRALIA: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 505 TABLE 817 AUSTRALIA: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 505 TABLE 818 AUSTRALIA: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 506 TABLE 819 AUSTRALIA: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 506 TABLE 820 AUSTRALIA: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 506 TABLE 821 AUSTRALIA: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 507 TABLE 822 AUSTRALIA: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION) 507 TABLE 823 AUSTRALIA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 508 TABLE 824 AUSTRALIA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 508 TABLE 825 AUSTRALIA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 508 TABLE 826 AUSTRALIA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 509 TABLE 827 AUSTRALIA: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 509 TABLE 828 AUSTRALIA: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION) 509 TABLE 829 AUSTRALIA: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION) 510 TABLE 830 AUSTRALIA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 510 TABLE 831 AUSTRALIA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 511 TABLE 832 AUSTRALIA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 511 TABLE 833 SOUTH KOREA: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION) 512 TABLE 834 SOUTH KOREA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 512 TABLE 835 SOUTH KOREA: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 513 TABLE 836 SOUTH KOREA: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 513 TABLE 837 SOUTH KOREA: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 514 TABLE 838 SOUTH KOREA: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 514 TABLE 839 SOUTH KOREA: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 515 TABLE 840 SOUTH KOREA: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 515 TABLE 841 SOUTH KOREA: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION) 516 TABLE 842 SOUTH KOREA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 516 TABLE 843 SOUTH KOREA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 517 TABLE 844 SOUTH KOREA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 517 TABLE 845 SOUTH KOREA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 517 TABLE 846 SOUTH KOREA: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 518 TABLE 847 SOUTH KOREA: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION) 518 TABLE 848 SOUTH KOREA: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION) 518 TABLE 849 SOUTH KOREA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 519 TABLE 850 SOUTH KOREA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 519 TABLE 851 SOUTH KOREA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 519 TABLE 852 REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION) 520 TABLE 853 REST OF ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 521 TABLE 854 REST OF ASIA PACIFIC: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 521 TABLE 855 REST OF ASIA PACIFIC: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 522 TABLE 856 REST OF ASIA PACIFIC: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 522 TABLE 857 REST OF ASIA PACIFIC: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 523 TABLE 858 REST OF ASIA PACIFIC: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 523 TABLE 859 REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 524 TABLE 860 REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION) 524 TABLE 861 REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 525 TABLE 862 REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 525 TABLE 863 REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 525 TABLE 864 REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 526 TABLE 865 REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 526 TABLE 866 REST OF ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION) 526 TABLE 867 REST OF ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION) 527 TABLE 868 REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 527 TABLE 869 REST OF ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 528 TABLE 870 REST OF ASIA PACIFIC: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 528 TABLE 871 LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 529 TABLE 872 LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION) 529 TABLE 873 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 530 TABLE 874 LATIN AMERICA: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 530 TABLE 875 LATIN AMERICA: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 531 TABLE 876 LATIN AMERICA: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 531 TABLE 877 LATIN AMERICA: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 532 TABLE 878 LATIN AMERICA: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 532 TABLE 879 LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 533 TABLE 880 LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION) 533 TABLE 881 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 534 TABLE 882 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 534 TABLE 883 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 534 TABLE 884 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 535 TABLE 885 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 535 TABLE 886 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION) 535 TABLE 887 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION) 536 TABLE 888 LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 536 TABLE 889 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 537 TABLE 890 LATIN AMERICA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 537 TABLE 891 BRAZIL: BRAZIL: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION) 538 TABLE 892 BRAZIL: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 538 TABLE 893 BRAZIL: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 538 TABLE 894 BRAZIL: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 539 TABLE 895 BRAZIL: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 539 TABLE 896 BRAZIL: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 539 TABLE 897 BRAZIL: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 540 TABLE 898 BRAZIL: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 540 TABLE 899 BRAZIL: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION) 541 TABLE 900 BRAZIL: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 541 TABLE 901 BRAZIL: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 542 TABLE 902 BRAZIL: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 542 TABLE 903 BRAZIL: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 542 TABLE 904 BRAZIL: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 543 TABLE 905 BRAZIL: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION) 543 TABLE 906 BRAZIL: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION) 543 TABLE 907 BRAZIL: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 544 TABLE 908 BRAZIL: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 544 TABLE 909 BRAZIL: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 544 TABLE 910 MEXICO: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION) 545 TABLE 911 MEXICO: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 545 TABLE 912 MEXICO: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 546 TABLE 913 MEXICO: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 546 TABLE 914 MEXICO: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 547 TABLE 915 MEXICO: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 547 TABLE 916 MEXICO: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 547 TABLE 917 MEXICO: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 548 TABLE 918 MEXICO: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION) 548 TABLE 919 MEXICO: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 549 TABLE 920 MEXICO: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 549 TABLE 921 MEXICO: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 549 TABLE 922 MEXICO: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 550 TABLE 923 MEXICO: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 550 TABLE 924 MEXICO: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION) 550 TABLE 925 MEXICO: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION) 551 TABLE 926 MEXICO: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 551 TABLE 927 MEXICO: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 552 TABLE 928 MEXICO: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 552 TABLE 929 ARGENTINA: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION) 553 TABLE 930 ARGENTINA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 553 TABLE 931 ARGENTINA: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 553 TABLE 932 ARGENTINA: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 554 TABLE 933 ARGENTINA: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 554 TABLE 934 ARGENTINA: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 554 TABLE 935 ARGENTINA: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 555 TABLE 936 ARGENTINA: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 555 TABLE 937 ARGENTINA: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION) 556 TABLE 938 ARGENTINA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 556 TABLE 939 ARGENTINA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 557 TABLE 940 ARGENTINA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 557 TABLE 941 ARGENTINA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 557 TABLE 942 ARGENTINA: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 558 TABLE 943 ARGENTINA: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION) 558 TABLE 944 ARGENTINA: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION) 558 TABLE 945 ARGENTINA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 559 TABLE 946 ARGENTINA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 559 TABLE 947 ARGENTINA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 559 TABLE 948 REST OF LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION) 560 TABLE 949 REST OF LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 560 TABLE 950 REST OF LATIN AMERICA: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 561 TABLE 951 REST OF LATIN AMERICA: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 561 TABLE 952 REST OF LATIN AMERICA: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 562 TABLE 953 REST OF LATIN AMERICA: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 562 TABLE 954 REST OF LATIN AMERICA: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 562 TABLE 955 REST OF LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 563 TABLE 956 REST OF LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION) 563 TABLE 957 REST OF LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 564 TABLE 958 REST OF LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 564 TABLE 959 REST OF LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 564 TABLE 960 REST OF LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 565 TABLE 961 REST OF LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 565 TABLE 962 REST OF LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION) 565 TABLE 963 REST OF LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION) 566 TABLE 964 REST OF LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 566 TABLE 965 REST OF LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 567 TABLE 966 REST OF LATIN AMERICA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 567 TABLE 967 MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY REGION, 2024–2031 (USD MILLION) 568 TABLE 968 MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION) 568 TABLE 969 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 569 TABLE 970 MIDDLE EAST: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 569 TABLE 971 MIDDLE EAST: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 570 TABLE 972 MIDDLE EAST: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 570 TABLE 973 MIDDLE EAST: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 570 TABLE 974 MIDDLE EAST: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 571 TABLE 975 MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 571 TABLE 976 MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION) 572 TABLE 977 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 572 TABLE 978 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 573 TABLE 979 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 573 TABLE 980 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 573 TABLE 981 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 574 TABLE 982 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION) 574 TABLE 983 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION) 574 TABLE 984 MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 575 TABLE 985 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 575 TABLE 986 MIDDLE EAST: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 575 TABLE 987 GCC COUNTRIES: PROTEIN EXPRESSION MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 576 TABLE 988 GCC COUNTRIES: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION) 576 TABLE 989 GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 577 TABLE 990 GCC COUNTRIES: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 577 TABLE 991 GCC COUNTRIES: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 578 TABLE 992 GCC COUNTRIES: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 578 TABLE 993 GCC COUNTRIES: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 579 TABLE 994 GCC COUNTRIES: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 579 TABLE 995 GCC COUNTRIES: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 580 TABLE 996 GCC COUNTRIES: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION) 580 TABLE 997 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 581 TABLE 998 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 581 TABLE 999 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 581 TABLE 1000 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 582 TABLE 1001 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 582 TABLE 1002 GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION) 582 TABLE 1003 GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION) 583 TABLE 1004 GCC COUNTRIES: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 583 TABLE 1005 GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 584 TABLE 1006 GCC COUNTRIES: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 584 TABLE 1007 SAUDI ARABIA: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION) 585 TABLE 1008 SAUDI ARABIA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 585 TABLE 1009 SAUDI ARABIA: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 586 TABLE 1010 SAUDI ARABIA: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 586 TABLE 1011 SAUDI ARABIA: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 587 TABLE 1012 SAUDI ARABIA: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 587 TABLE 1013 SAUDI ARABIA: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 587 TABLE 1014 SAUDI ARABIA: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 588 TABLE 1015 SAUDI ARABIA: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION) 588 TABLE 1016 SAUDI ARABIA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 589 TABLE 1017 SAUDI ARABIA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 589 TABLE 1018 SAUDI ARABIA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 589 TABLE 1019 SAUDI ARABIA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 590 TABLE 1020 SAUDI ARABIA: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 590 TABLE 1021 SAUDI ARABIA: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION) 590 TABLE 1022 SAUDI ARABIA: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION) 591 TABLE 1023 SAUDI ARABIA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 591 TABLE 1024 SAUDI ARABIA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 592 TABLE 1025 SAUDI ARABIA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 592 TABLE 1026 UAE: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION) 593 TABLE 1027 UAE: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 593 TABLE 1028 UAE: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 594 TABLE 1029 UAE: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 594 TABLE 1030 UAE: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 595 TABLE 1031 UAE: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 595 TABLE 1032 UAE: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 595 TABLE 1033 UAE: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 596 TABLE 1034 UAE: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION) 596 TABLE 1035 UAE: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 597 TABLE 1036 UAE: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 597 TABLE 1037 UAE: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 597 TABLE 1038 UAE: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 598 TABLE 1039 UAE: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 598 TABLE 1040 UAE: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION) 598 TABLE 1041 UAE: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION) 599 TABLE 1042 UAE: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 599 TABLE 1043 UAE: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 600 TABLE 1044 UAE: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 600 TABLE 1045 REST OF GCC COUNTRIES: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION) 601 TABLE 1046 REST OF GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 601 TABLE 1047 REST OF GCC COUNTRIES: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 601 TABLE 1048 REST OF GCC COUNTRIES: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 602 TABLE 1049 REST OF GCC COUNTRIES: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 602 TABLE 1050 REST OF GCC COUNTRIES: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 603 TABLE 1051 REST OF GCC COUNTRIES: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 603 TABLE 1052 REST OF GCC COUNTRIES: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 604 TABLE 1053 REST OF GCC COUNTRIES: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION) 604 TABLE 1054 REST OF GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 605 TABLE 1055 REST OF GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 605 TABLE 1056 REST OF GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 605 TABLE 1057 REST OF GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 606 TABLE 1058 REST OF GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 606 TABLE 1059 REST OF GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION) 606 TABLE 1060 REST OF GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION) 607 TABLE 1061 REST OF GCC COUNTRIES: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 607 TABLE 1062 REST OF GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 608 TABLE 1063 REST OF GCC COUNTRIES: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 608 TABLE 1064 REST OF MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION) 609 TABLE 1065 REST OF MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 609 TABLE 1066 REST OF MIDDLE EAST: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 610 TABLE 1067 REST OF MIDDLE EAST: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 610 TABLE 1068 REST OF MIDDLE EAST: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 611 TABLE 1069 REST OF MIDDLE EAST: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 611 TABLE 1070 REST OF MIDDLE EAST: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 611 TABLE 1071 REST OF MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 612 TABLE 1072 REST OF MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION) 612 TABLE 1073 REST OF MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 613 TABLE 1074 REST OF MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 613 TABLE 1075 REST OF MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 613 TABLE 1076 REST OF MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 614 TABLE 1077 REST OF MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 614 TABLE 1078 REST OF MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION) 614 TABLE 1079 REST OF MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION) 615 TABLE 1080 REST OF MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 615 TABLE 1081 REST OF MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 616 TABLE 1082 REST OF MIDDLE EAST: PROTEIN EXPRESSION SERVICE MARKET, BY END USER, 2024–2031 (USD MILLION) 616 TABLE 1083 AFRICA: PROTEIN EXPRESSION MARKET, BY OFFERING, 2024–2031 (USD MILLION) 617 TABLE 1084 AFRICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 617 TABLE 1085 AFRICA: PROTEIN EXPRESSION REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 618 TABLE 1086 AFRICA: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 618 TABLE 1087 AFRICA: PROTEIN EXPRESSION CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 619 TABLE 1088 AFRICA: PROTEIN EXPRESSION KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 619 TABLE 1089 AFRICA: PROTEIN EXPRESSION SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 619 TABLE 1090 AFRICA: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 620 TABLE 1091 AFRICA: PROTEIN EXPRESSION MARKET, BY TYPE, 2024–2031 (USD MILLION) 620 TABLE 1092 AFRICA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 621 TABLE 1093 AFRICA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 621 TABLE 1094 AFRICA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 621 TABLE 1095 AFRICA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 622 TABLE 1096 AFRICA: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY TYPE, 2024–2031 (USD MILLION) 622 TABLE 1097 AFRICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY SCALE OF OPERATION, 2024–2031 (USD MILLION) 622 TABLE 1098 AFRICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY PROTEIN MODALITY, 2024–2031 (USD MILLION) 623 TABLE 1099 AFRICA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 623 TABLE 1100 AFRICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 624 TABLE 1101 AFRICA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 624 TABLE 1102 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN PROTEIN EXPRESSION MARKET 626 TABLE 1103 PROTEIN EXPRESSION MARKET: DEGREE OF COMPETITION 629 TABLE 1104 PROTEIN EXPRESSION MARKET: REGION FOOTPRINT 633 TABLE 1105 PROTEIN EXPRESSION MARKET: OFFERING FOOTPRINT 634 TABLE 1106 PROTEIN EXPRESSION MARKET: TYPE FOOTPRINT 635 TABLE 1107 PROTEIN EXPRESSION MARKET: APPLICATION FOOTPRINT 637 TABLE 1108 PROTEIN EXPRESSION MARKET: DETAILED LIST OF KEY STARTUPS/SMES 640 TABLE 1109 PROTEIN EXPRESSION MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 641 TABLE 1110 PROTEIN EXPRESSION MARKET: PRODUCT & SERVICE LAUNCHES, JANUARY 2023–MAY 2026 644 TABLE 1111 PROTEIN EXPRESSION MARKET: DEALS, JANUARY 2023–MAY 2026 645 TABLE 1112 PROTEIN EXPRESSION MARKET: EXPANSIONS, JANUARY 2023–MAY 2026 646 TABLE 1113 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 647 TABLE 1114 THERMO FISHER SCIENTIFIC INC.: PRODUCTS & SERVICES OFFERED 648 TABLE 1115 THERMO FISHER SCIENTIFIC INC.: PRODUCT & SERVICE LAUNCHES, JANUARY 2023–MAY 2026 652 TABLE 1116 THERMO FISHER SCIENTIFIC, INC.: DEALS, JANUARY 2023–MAY 2026 653 TABLE 1117 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2023–MAY 2026 653 TABLE 1118 MERCK KGAA: COMPANY OVERVIEW 655 TABLE 1119 MERCK KGAA: PRODUCTS & SERVICES OFFERED 656 TABLE 1120 MERCK KGAA: DEALS, JANUARY 2023–MAY 2026 659 TABLE 1121 MERCK KGAA: EXPANSIONS, JANUARY 2023–MAY 2026 659 TABLE 1122 DANAHER CORPORATION: COMPANY OVERVIEW 662 TABLE 1123 DANAHER CORPORATION: PRODUCTS & SERVICES OFFERED 663 TABLE 1124 DANAHER CORPORATION: PRODUCT LAUNCHES, JANUARY 2023–MAY 2026 665 TABLE 1125 DANAHER CORPORATION: DEALS, JANUARY 2023–MAY 2026 666 TABLE 1126 DANAHER CORPORATION: EXPANSIONS, JANUARY 2023–MAY 2026 666 TABLE 1127 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW 668 TABLE 1128 AGILENT TECHNOLOGIES, INC.: PRODUCTS & SERVICES OFFERED 669 TABLE 1129 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES, JANUARY 2023–MAY 2026 672 TABLE 1130 AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2023–MAY 2026 672 TABLE 1131 SARTORIUS AG: COMPANY OVERVIEW 674 TABLE 1132 SARTORIUS AG: PRODUCTS & SERVICES OFFERED 675 TABLE 1133 SARTORIUS AG: DEALS, JANUARY 2023–MAY 2026 676 TABLE 1134 SARTORIUS AG: EXPANSIONS, JANUARY 2023–MAY 2026 676 TABLE 1135 GENSCRIPT: COMPANY OVERVIEW 678 TABLE 1136 GENSCRIPT: PRODUCTS & SERVICES OFFERED 679 TABLE 1137 GENSCRIPT: PRODUCT/SERVICE LAUNCHES, JANUARY 2023–MAY 2026 680 TABLE 1138 TAKARA BIO INC.: COMPANY OVERVIEW 681 TABLE 1139 TAKARA BIO INC.: PRODUCTS & SERVICES OFFERED 682 TABLE 1140 TAKARA BIO INC.: EXPANSIONS, JANUARY 2023–MAY 2026 684 TABLE 1141 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW 685 TABLE 1142 BIO-RAD LABORATORIES, INC.: PRODUCTS & SERVICES OFFERED 686 TABLE 1143 BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES, JANUARY 2023–MAY 2026 688 TABLE 1144 BIO-RAD LABORATORIES, INC.: DEALS, JANUARY 2023–MAY 2026 688 TABLE 1145 QIAGEN: COMPANY OVERVIEW 689 TABLE 1146 QIAGEN: PRODUCTS & SERVICES OFFERED 690 TABLE 1147 QIAGEN: PRODUCT LAUNCHES, JANUARY 2023- APRIL 2026 691 TABLE 1148 BIO-RAD LABORATORIES, INC.: DEALS, JANUARY 2023- APRIL 2026 691 TABLE 1149 CHARLES RIVER LABORATORIES: COMPANY OVERVIEW 692 TABLE 1150 CHARLES RIVER LABORATORIES: PRODUCTS & SERVICES OFFERED 693 TABLE 1151 CHARLES RIVER LABORATORIES: PRODUCT/SERVICE LAUNCHES, JANUARY 2023- APRIL 2026 694 TABLE 1152 CORNING INCORPORATED: COMPANY OVERVIEW 695 TABLE 1153 CORNING INCORPORATED: PRODUCTS & SERVICES OFFERED 696 TABLE 1154 CORNING INCORPORATED: PRODUCT LAUNCHES, JANUARY 2023- APRIL 2026 698 TABLE 1155 LONZA: COMPANY OVERVIEW 699 TABLE 1156 LONZA: PRODUCTS & SERVICES OFFERED 700 TABLE 1157 LONZA: PRODUCT LAUNCHES, JANUARY 2023–MAY 2026 702 TABLE 1158 LONZA: DEALS, JANUARY 2023–MAY 2026 702 TABLE 1159 FUJIFILM CORPORATION: COMPANY OVERVIEW 703 TABLE 1160 FUJIFILM CORPORATION: PRODUCTS & SERVICES OFFERED 704 TABLE 1161 FUJIFILM CORPORATION: PRODUCT LAUNCHES, JANUARY 2023–MAY 2026 706 TABLE 1162 FUJIFILM CORPORATION: EXPANSIONS, JANUARY 2023–MAY 2026 706 TABLE 1163 SYNGENE INTERNATIONAL LIMITED: COMPANY OVERVIEW 707 TABLE 1164 SYNGENE INTERNATIONAL LIMITED: PRODUCTS & SERVICES OFFERED 708 TABLE 1165 SYNGENE INTERNATIONAL LIMITED: PRODUCT LAUNCHES, JANUARY 2023–MAY 2026 708 TABLE 1166 LGC LIMITED: COMPANY OVERVIEW 709 TABLE 1167 LGC LIMITED: PRODUCTS & SERVICES OFFERED 710 TABLE 1168 EUROFINS SCIENTIFIC: COMPANY OVERVIEW 712 TABLE 1169 EUROFINS SCIENTIFIC: PRODUCTS & SERVICES OFFERED 713 TABLE 1170 EUROFINS SCIENTIFIC: EXPANSIONS, JANUARY 2023- APRIL 2026 714 TABLE 1171 AJINOMOTO CO., INC.: COMPANY OVERVIEW 715 TABLE 1172 AJINOMOTO CO., INC.: PRODUCTS & SERVICES OFFERED 716 TABLE 1173 AJINOMOTO CO., INC.: DEALS, JANUARY 2023- APRIL 2026 717 TABLE 1174 PROMEGA CORPORATION: COMPANY OVERVIEW 718 TABLE 1175 SINO BIOLOGICAL, INC.: COMPANY OVERVIEW 719 TABLE 1176 RAYBIOTECH, INC.: COMPANY OVERVIEW 720 TABLE 1177 BIONEER CORPORATION: COMPANY OVERVIEW 721 TABLE 1178 ORIGENE TECHNOLOGIES, INC.: COMPANY OVERVIEW 722 TABLE 1179 NEW ENGLAND BIOLABS: COMPANY OVERVIEW 723 TABLE 1180 ACCURUS BIOSCIENCES: COMPANY OVERVIEW 724 TABLE 1181 ARAGEN LIFE SCIENCES LTD.: COMPANY OVERVIEW 725 TABLE 1182 OXFORD EXPRESSION TECHNOLOGIES LTD: COMPANY OVERVIEW 726 TABLE 1183 PROTEOGENIX INC.: COMPANY OVERVIEW 727 TABLE 1184 ABEOMICS: COMPANY OVERVIEW 728 TABLE 1185 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS 737 FIGURE 1 MARKET SCENARIO 72 FIGURE 2 GLOBAL PROTEIN EXPRESSION MARKET, 2024–2031 72 FIGURE 3 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN PROTEIN EXPRESSION MARKET, 2023–2026 73 FIGURE 4 DISRUPTIONS INFLUENCING GROWTH OF PROTEIN EXPRESSION MARKET 74 FIGURE 5 HIGH-GROWTH SEGMENTS IN PROTEIN EXPRESSION MARKET, 2026–2031 75 FIGURE 6 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN THE PROTEIN EXPRESSION MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD 76 FIGURE 7 CONTINUOUS INNOVATION IN EXPRESSION TECHNOLOGIES TO DRIVE GROWTH IN PROTEIN EXPRESSION MARKET 77 FIGURE 8 PRODUCT SEGMENT IN NORTH AMERICA ACCOUNTED FOR LARGEST MARKET SHARE IN 2025 78 FIGURE 9 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 79 FIGURE 10 PROTEIN EXPRESSION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 80 FIGURE 11 PROTEIN EXPRESSION MARKET: PORTER'S FIVE FORCES ANALYSIS 87 FIGURE 12 PROTEIN EXPRESSION PRODUCTS MARKET: VALUE CHAIN ANALYSIS 91 FIGURE 13 PROTEIN EXPRESSION SERVICES MARKET: VALUE CHAIN ANALYSIS 92 FIGURE 14 PROTEIN EXPRESSION MARKET: ECOSYSTEM ANALYSIS 93 FIGURE 15 AVERAGE SELLING PRICE OF PROTEIN EXPRESSION SYSTEMS, BY KEY PLAYER 95 FIGURE 16 INDICATIVE SELLING PRICE TREND OF PROTEIN EXPRESSION SYSTEMS, BY REGION, 2025 (USD) 96 FIGURE 17 PROTEIN EXPRESSION MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 101 FIGURE 18 VC/PRIVATE EQUITY INVESTMENT TRENDS & STARTUP LANDSCAPE 102 FIGURE 19 TOP APPLICANTS/OWNERS (COMPANIES) FOR PROTEIN EXPRESSION PATENTS, 2015–2025 111 FIGURE 20 IMPACT OF AI/GEN AI ON PROTEIN EXPRESSION MARKET 114 FIGURE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING 126 FIGURE 22 KEY BUYING CRITERIA, BY END USER 126 FIGURE 23 NORTH AMERICA: PROTEIN EXPRESSION MARKET SNAPSHOT 375 FIGURE 24 ASIA PACIFIC: PROTEIN EXPRESSION MARKET SNAPSHOT 471 FIGURE 25 REVENUE ANALYSIS OF KEY PLAYERS, 2023–2025 (USD MILLION) 627 FIGURE 26 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025 628 FIGURE 27 PROTEIN EXPRESSION MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 631 FIGURE 28 PROTEIN EXPRESSION MARKET: COMPANY FOOTPRINT 632 FIGURE 29 PROTEIN EXPRESSION MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 639 FIGURE 30 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 642 FIGURE 31 EV/EBITDA OF KEY VENDORS 642 FIGURE 32 PROTEIN EXPRESSION MARKET: BRAND/PRODUCT COMPARISON 643 FIGURE 33 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2025) 648 FIGURE 34 MERCK KGAA: COMPANY SNAPSHOT (2025) 656 FIGURE 35 DANAHER CORPORATION: COMPANY SNAPSHOT (2025) 663 FIGURE 36 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2025) 669 FIGURE 37 SARTORIUS AG: COMPANY SNAPSHOT (2025) 675 FIGURE 38 GENSCRIPT: COMPANY SNAPSHOT (2025) 678 FIGURE 39 TAKARA BIO INC.: COMPANY SNAPSHOT (2025) 682 FIGURE 40 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2025) 686 FIGURE 41 QIAGEN: COMPANY SNAPSHOT (2025) 689 FIGURE 42 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2025) 693 FIGURE 43 CORNING INCORPORATED: COMPANY SNAPSHOT (2025) 696 FIGURE 44 LONZA: COMPANY SNAPSHOT (2025) 700 FIGURE 45 FUJIFILM CORPORATION: COMPANY SNAPSHOT (2024) 704 FIGURE 46 SYNGENE INTERNATIONAL LIMITED: COMPANY SNAPSHOT (2025) 707 FIGURE 47 LGC LIMITED: COMPANY SNAPSHOT (2025) 710 FIGURE 48 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2025) 713 FIGURE 49 AJINOMOTO CO., INC.: COMPANY SNAPSHOT (2025) 716 FIGURE 50 RESEARCH DESIGN 729 FIGURE 51 PROTEIN EXPRESSION MARKET: BREAKDOWN OF PRIMARIES 731 FIGURE 52 PROTEIN EXPRESSION MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2025 732 FIGURE 53 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2025 733 FIGURE 54 REVENUE SHARE ANALYSIS: ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC, INC. (2025) 733 FIGURE 55 MARKET SIZE VALIDATION FROM PRIMARY SOURCES 734 FIGURE 56 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 735 FIGURE 57 PROTEIN EXPRESSION MARKET CAGR PROJECTIONS: 737 FIGURE 58 DATA TRIANGULATION METHODOLOGY 738

同分類最新報告（醫療與生命科學）

查看醫療與生命科學全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們